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Abstract
Polymer-based microelectrophoresis was investigated to analyze known
(mutation detection) and unknown (mutation scanning) low-abundant mutations in
genomic DNA with high diagnostic value for colorectal cancers.

For our mutation

detection assays, point mutations in the K-ras oncogene were identified using the ligase
detection reaction (LDR). For the mutation scanning assay, which searches for sporadic
mutations, an EndoV-LDR assay was utilized with mutations in the p53 tumor
suppressor gene used as a model.
A

poly(methylmethacrylate),

PMMA,

microchip

filled

with

a

4%

linear

polyacrylamide (LPA) gel was used to electrophoretically sort products formed from
LDRs, which produced oligonucleotides <65 bp in length. Using microchip
electrophoresis with the LPA, a 44 bp ligation product was resolved from a 100-fold
molar excess of unligated primers (25 bp) in approximately 120 s, which was ~17 times
faster than conventional capillary gel electrophoresis.
In order to simplify the electrophoretic process and further reduce development
time, the LDR products were sorted in the absence of the sieving gel using free solution
conjugate electrophoresis (FSCE). FSCE incorporated polyamide “drag-tags” onto LDR
primers, which provided DNA fragment mobilities in free solution that were dependent
upon their size. LDR/drag-tagged (LDR-dt) products could be formed in a multiplexed
format for mutant-to-wild-type ratios as low as 1 to 100 with single base resolution.
Separations were conducted using capillary array electrophoresis (CAE) and PMMA
microchips filled with only a TRIS buffer. Analysis times for the LDR-dt products were
less than 11 min using CAE and ~85 s for PMMA microchips with high reproducible
migration times within and between microchips.
[xvi]

PMMA-based microchips were also evaluated for the identification of sporadic
mutations using an endonuclease V – LDR (Endo V/LDR) technique. Endo V cleaves
heteroduplexed DNA one base 3’ of single-base mismatched sites as well as nicking
DNA at some matched sites as LDR reseals miscleaved sites to reduce false positive
signals. Results suggested that Endo V/LDR products from p53 mutations could be
successfully separated and detected using a PMMA microfluidic chip filled with a
sparsely cross-linked replaceable polyacrylamide gel in less than 6 min, which was
approximately 10-fold shorter compared to CAE.

[xvii]

Chapter 1: Advances in Genotyping
1.1 Overview of DNA
All of the tremendously diverse biological attributes of life are governed by the
mere sequence of a simple, four-alphabet genetic code – that of deoxyribonucleic acid
(DNA). Housed in the nuclei of cells in dense bundles known as chromosomes, DNA is
a biopolymer containing the genetic instructions that transcribe ribonucleic acid (RNA)
molecules, which are in turn translated into functional, regulatory enzymes or highly
organized structural components ascending from proteins to organelles to cells. DNA
exists in long strands comprised of four unique nucleosides: adenine (A), cytosine (C),
guanine (G) and thymine (T) (see Figure 1.1). Each strand is held together by a sugarphosphate backbone, which gives the macromolecule a net negative charge. Together,
a single sugar-phosphate group and nucleoside comprise DNA monomer units known
as nucleotides. Through Watson-Crick pairing, complementary DNA strands conform
into a double helix via hydrogen bonding between coordinated G/C and A/T bases as
shown in Figure 1.2. These weak hydrogen bonds permit two complementary strands

Figure 1.1. The chemical structures of the adenine, guanine, cytosine and thymine DNA
nucleosides.

[1]

of DNA to easily separate and reestablish pairings under certain physiological
conditions, such as the process of mitosis whereby two daughter cells are created with
the exact genetic code as the parent cell.

Figure 1.2. An annotated diagram depicting the DNA double helix highlighting its
fundamental components.
Adapted from http://cnx.org/content/m12382/1.5/ with
permission.

[2]

1.2 Overview of the Human Genome
In June 2000, some 50 years after the discovery of the DNA double helix, the
rough draft sequencing of the approximate three billion bases in the human genome
was completed due to the monumental undertaking of the Human Genome Project
(HGP). Upon the initial deciphering of the human genome, we now know that our
genomes are nearly 99% identical and that they only contain approximately 30,000 –
40,000 genes instead of the hypothesized 100,000 (one gene per protein), leaving
about 1% of the human genome that codes for functional components that regulate
various cellular machinery and processes.

However, this small percentage of the

human genome accounts for over 90% of all sequence variations that make each
individual unique [1, 2].
While this rough draft of the human genome has already aided biomedical
research, much more sequencing detail is needed. In fact, it has been predicted that
medical care will one day be tailored to each individual’s genomic sequence [3]. Aside
from the discovery of the remaining unidentified genes, the challenge that now remains
is identifying (genotyping) the subtle differences within various regions of the genome
known as polymorphisms that are produced from either environmental or inherited
conditions.

Upon identification, numerous polymorphisms - base substitutions,

deletions, insertions, or frameshifts (see Figure 1.3) - within an active gene-coding
region can be used as markers to monitor for the presence of or even susceptibility to
developing a given disease. Most polymorphisms are classified as single nucleotide
polymorphisms (SNP)s wherein a single base is substituted, which can potentially lead
to genetic mutations and thus, the development of deleterious conditions such as sickle
cell anemia, muscular dystrophy and many forms of cancer to name just a few. For
[3]

instance, muscular dystrophy, a highly debilitating and fatal X chromosome-linked
muscle disorder affecting approximately 1 in 3,500 new-born males, has been traced to
irregularities in a single gene, dystrophin, measuring 2.4 Mb making it the largest found
in humans [4].

Figure 1.3. Depiction of base substitutions, insertions, deletions and frameshifts
comprising the different types of DNA sequence polymorphisms.

Genetic sequencing information also plays a key role in the development of
presymptomatic screening assays for the early diagnosis of disease states. Cancers,
uncontrolled cell growth initiated by an accumulation of point mutations in functional
gene regions promoting tumorigenesis, are of particular interest as the relationship
between time of discovery and survival rates has been well documented in the scientific
literature [5].
The onset of colorectal cancer, for example, is highly associated with 19 known
SNPs within codons 12, 13, and 61 of the K-ras gene, which convert the amino acid
[4]

glycine to valine in these critical positions, making the gene oncogenic. The ras gene is
a signal transduction protein producer (GTPase), which under normal functionality is
activated by guanine exchange factors and inactivated by GTPase-activating proteins
via GTP hydrolysis of ras back to its GDP form.

However, the K-ras oncogene

continually encodes 21 Kb hydrolysis-resistant GTPase analogs (cell growth signals),
thus stimulating growth and differentiation of cells autonomously [6, 7]. On the other
hand, tumor suppressor genes, such as the p53 gene, are also highly associated with
the onset of colorectal cancer. The p53 tumor suppressor protein is a multi-functional
transcription factor that regulates cellular processes affecting proliferation and induces
growth arrest and apoptosis via several pathways [8].

These mutations occur

sporadically throughout large spans of the gene, mostly in exons 5 – 9 [9]. Therefore,
both oncogenic and tumor suppressor mutations must be assessed for accurate
diagnosis of the disease.
1.3 Genotyping with Fragment Analysis Methods (More information provided in
Chapter 2)
Equipped with vast insight from the HGP including the locations of genes and
specific DNA bases within them responsible for the onset of particular disease states,
small fragments (~100 – 500 bp) encompassing these regions are typically generated
and probed.

There is an array of fragment analysis genotyping methods including

single-strand conformational polymorphism (SSCP), heteroduplex analysis (HA),
minisequencing,

short

tandem

repeats

(STR)s,

restriction

fragment

length

polymorphisms (RFLP)s, and the ligase detection reaction (LDR) to name a few, all of
which will be discussed in great detail in the following chapter. Although sequencing is

[5]

still considered the genotyping gold standard, these methods are often used in lieu of
sequencing because it is a relatively time-consuming, a laborious process.
Each fragment analysis method has its advantages and disadvantages with
respect to simplicity, sensitivity, ease of multiplexing, throughput, and cost. Therefore,
the choice of SNP genotyping method varies, depending on the specific needs and
resources of each laboratory.

Central to most fragment analysis techniques is the

utilization of the polymerase chain reaction (PCR), which has the ability to exponentially
amplify a single copy of a gene fragment of interest into millions of synthetic copies as
shown in Figure 4 [10]. Thereafter, normal and mutagenic DNA fragments are directly
deciphered by either conformational differences due to sequence composition (i.e.,
SSCP and HA) or size differences elucidated via electrophoretic-based separations
(i.e., STR). Other methods require subsequent treatments with enzymes that either
cleave DNA fragments with endonucleases (e.g., RFLP) or conjoin DNA fragments
using ligases (e.g., LDR) and are highly dependent on the ability of such enzymes to
recognize and act only upon DNA bases of interest within a sequence. Consequently,
thousands of novel enzymes have been discovered, characterized, and utilized in DNA
treatments according to their specificity [11].
1.4 Genotyping Technology (More information provided in Chapter 2)
1.4.1 Electrophoresis of DNA
Gel electrophoresis is the method of choice for sorting DNA fragments.

In

general, electrophoresis is a method used to separate a heterogeneous population of
charged particles in a conductive medium under an electric field. Given DNA is a freedraining molecule that has a constant size-to-charge ratio that will not permit sizesorting in free-solution, a porous sieving material must be suspended in the conductive
[6]

medium in order to induce frictional drag on DNA molecules [12].

Under such

parameters, an applied electrical field results in the electrophoretic migration of DNAs
with a frictional force acting in the opposite direction. The electrical force ( ) is given by
the equation:
(1.1),
where

is the net charge on the molecule and

is the applied electric field. The

frictional force ( ) is described by the equation:
(1.2),
where

is the translational friction coefficient and

and

are the distance and time

Figure 1.4. Illustration of PCR process used to amplify segments of DNA from
http://www.sumanasinc.com/webcontent/animations/content/pcr.html., 2007.
[7]

increments, respectively.

Under steady-state conditions where

and

are

counterbalanced, DNA migrates with a steady-state velocity ( );
(1.3).
Therefore, the movement of DNA molecules can be quantified in terms of its
electrophoretic mobility ( ) from the equation:
(1.4).
Substituting equation (1.3) into (1.4) yields:
(1.5),
which describes the electrophoretic mobility of a DNA molecule in terms of its charge
and frictional components. As mentioned previously, DNA is a net negatively charged
molecule with a constant size-to-charge ratio. Since

α ( ), the number of base pairs

in a DNA chain, and each of these units contribute proportionally to the overall frictional
drag exerted on the molecule ( α

):
(1.6).

Thus, the electrophoretic mobility of a population of DNA molecules in free solution is
uniform, which explains the necessity of porous sieving materials for their
electrophoretic separation into well-resolved zones or bands as shown in Figure 1.5.
1.4.2 DNA Sieving Media
It was first reported in 1967 that separation profiles utilizing gels occur because smaller
DNA fragments traverse porous media at greater velocities than larger DNA chains,
which are subjected to greater friction under an electric field [13].

With gel

electrophoresis, the extent to which a mixture of DNAs is resolved depends heavily on
the pore size of a gel medium relative to the DNA size distribution. For DNA genotyping
[8]

separations, a host of entangled polymer in solutions of varying concentrations (see
Table 1.1) or chemically cross-linked networks in solution is commonly utilized.
Entangled

polymers

in

solution

are

ideal

for

automated

capillary

array

electrophoresis(CAE) systems because they are easily replaced between runs to
prevent contamination during successive analyses (see Figure 1.6).

Figure 1.5. An illustration of the use of a porous gel medium to electrophoretically sort
a mixed DNA population into bands in a slab gel and capillary gel format. Capillary gel
format from www.chnola-research.org/.../capilary.htm, 2004.

Such matrices include poly (ethyleneoxide), PEO, hydroxyethyl cellulose and
linear polyacrylamide (LPA) to name a few [14]. LPA and its derivatives having ultrahigh molar mass are the most popular sieving material due to their high hydrophilicity
and excellent DNA separation ability [15]. On the other hand, non-replaceable crosslinked polyacrylamides in solution are typically used in slab gel formats and have the
ability to resolve DNA ranging from 6 to 1,000 bp given the appropriate concentration
and degree of cross-linking [16].
[9]

Figure 1.6. Schematic representation of linear and cross-linked polymers in solution.

1.4.3 Dispersion and Band Broadening
The ability to resolve a mixture of solutes into homogeneous zones or bands
depends on the length of each band, which in turn is dependent on the dispersion
processes that act on them. This dispersion leads to band broadening, which causes
migrating bands to overlap and become indistinct from each other. Such dispersion
processes include:

longitudinal molecular diffusion, thermal or convective diffusion,

nonspecific analyte-wall interactions, sample injections and noise presence in the
detector. Dispersion can be described as the total variance within the system,

,

which is given by the sum of several contributing factors:
(1.7),
where the subscripts refer to diffusion, temperature gradients, injection, adsorption and
detection, respectively. In an ideal system, longitudinal diffusion is the major contributor
to the total zone variance and all other dispersion factors are negligible.

For

electrophoretic separations of DNA performed with polymer matrices, longitudinal and
radial molecular diffusion do not contribute as much to band broadening as in free
solution separations because the rate at which DNA molecules diffuse in viscous media
(i.e., ~10-8 – 10-10 cm2/s) [17] is relatively low compared to the rate of diffusion in free
[10]

Table 1.1. Compilation of experimental conditions with replaceable polymers for high
performance DNA separations using capillary electrophoresis. Reprinted with
permission (see Appendix for references within Table) [14].

.
solution (i.e., ~10-7 cm2/s) [18]. As a result, higher efficiencies are achieved with gel
electrophoresis.
1.4.3.1 Electroosmotic Flow
Electroosmotic flow (EOF) is the bulk flow of a solution towards a cathode or
anode upon voltage application due to the formation of an electric double layer that
develops at the capillary surface/solution interface. This phenomenon occurs because
a plane of shear between the fixed and mobile layers creates a potential difference
between the layers known as the zeta potential, , which is determined by the charge of
[11]

a conduit wall. This phenomenon is dependent upon the surface charge of a conduit as
well as the pH and the ionic strength of buffered solutions. EOF can be expressed in
terms of mobility using the equation:
eof =


E


(1.8),

where ε is the dielectric constant. The electrophoretic mobility of a solute in the
presence of the EOF is termed the apparent mobility (µapp), which is expressed as:
app = eof - e

(1.9).

Both electroosmotic and electrophoretic flow within a microchannel have a flat profile as
shown in Figure 1.7, which is beneficial for band efficiencies.

However, EOF is

undesirable when performing DNA separations in capillaries because its mobility is
toward the cathode, opposing the electrophoretic mobility of negatively charged DNA,
which is toward the anode. Moreover, highly charged surfaces that lead to EOF also
result in unwanted analyte-wall interactions.

Thus, surface modifications are

administered to suppress EOF and analyte-wall interactions.

Figure 1.7. Plug flow profile and EOF in a capillary tube during electrophoresis adapted
from http://micromachine.stanford.edu/~dlaser/images/eof_capillary.jpg, 2006.
[12]

1.4.3.2 Surface Modification for Suppression of EOF
To reduce surface charge influences on the separations, the EOF in capillaries
must be either significantly reduced or eliminated. This is accomplished by coating
channel surfaces with polymeric materials. These coatings can either be static through
means of covalent attachment of the coating materials to the surface, or dynamic,
whereby a coating is adsorbed onto the wall. Both methods provide a homogeneous
surface to reduce dispersion effects, which is especially important as DNA separations
are dramatically affected by inhomogeneities in surface charges [19].
One of the earliest reports concerning chemical modifications of capillary
surfaces is the Hjerten coating method.

This modification involves the coating of

channel surfaces with a non-cross-linked polyacrylamide to eliminate the EOF in silica
capillaries through attachment of a thin layer of polyacrylamide groups by reacting the
SiO-

groups

with

γ

methacryloxypropyltrimethoxysilane

(γ-MAPS)

prior

to

polymerization [20].
Dynamic coatings are advantageous because they do not require timeconsuming chemical modifications.

Passivation is typically achieved by either pre-

rinsing the microchannel with a solution containing the adsorptive polymer or additive,
or by including the coating agents in the run buffer or separation medium. Dynamic
coating with self-coating sieving matrices such as poly(dimethylacrylamide) (PDMA) and
polyvinylpyrrolidone (PVP) are attractive since the coating is regenerated with each
refilling of the microchannel, which increases the
several analyses [21, 22].

[13]

reproducible of separations over

1.4.4 Characterization of Electropherograms
Upon electrophoretic separations, electropherograms reveal bands referred to as
peaks, whose dispersion can be measured by evaluating the width of the peak at its
base,

. For a Gaussian peak,
(1.10),

where  is the standard deviation of the peak. From this expression, efficiency,

, can

then be expressed as theoretical plates by:
(1.11),
where

is the effective length of the capillary (cm). Also, efficiency can be directly

related to the molecular diffusion by:
(1.12),
where

is the diffusion coefficient of the molecule,

(cm) and

is the total length of the capillary

is time. Substituting 1.12 into 1.11 yields the fundamental electrophoretic

expression for plate number:
(1.13).
Efficiency

can

also

be

calculated

directly

from

peak

parameters

in

an

electropherograms as shown in Figure 1.8 with the following expression:
(1.14),
where tm is the migration time of the peak (see Figure 1.8). The resulting value is then
normalized to an effective column length of one meter (plates/m).

For gel

electrophoresis, the major contributor to band broadening for a well-designed system is

[14]

longitudinal diffusion of the solute molecules. In this instance,

can be directly related

to the molecular diffusion by:
N=

El
2D

(1.15).

Resolution is the degree of separation between the target molecule(s) and other
molecules within a sample. It is the result of two factors: selectivity (the relative
difference in the retention of two peaks) and efficiency. Resolution is given by the
expression:
R=2

(tm2 - t m1 )
wb 2 + wb1

(1.16),

the difference in migration times divided by the average width of the two peaks at the
base. Resolution can also be calculated in terms of efficiency and mobility with the
expression:

Figure 1.8. Adjacent peaks in an electropherogram marking migration times and peak
widths from which efficiency and resolution can be calculated adapted from [23].
[15]

(1.17),
where

is the mean mobility of two neighboring components.

1.5 Evolution of Electrophoretic Genotyping Platforms
Driven by the enormous demand for electrophoretic systems with high
throughput capabilities, automated CAE systems were devised to replace cumbersome
slab gel systems. Due to a capillary’s ability to dissipate heat, higher electrical fields
can be sustained, and thus, faster separations can be performed.

Though these

commercial instruments remain effective, they are still relatively expensive to operate
and slow considering the ever expanding post-HGP genotyping demands including
disease, forensic and ongoing genome sequencing studies [24].

Meanwhile,

miniaturized microfluidic platforms have gained traction as electrophoretic devices with
the potential to satisfy these growing genotyping needs [24]. Just as CAE systems
improved upon slab gel systems for DNA sorting in terms of reduction in sample
consumption and speed of analysis, microfluidics have improved upon these same
factors of CAE systems by orders of magnitude (see Table 1.2). In addition, this

Table 1.2. Comparison of typical parameters associated with the given electrophoretic
formats.
Slab Gel

Capillary

Microchip

Analysis Time

2–8h

1–2h

0.5 – 10 min

Field Strengths

50 – 80 V/cm

100 – 300 V/cm

100 – 300 V/cm

Sample

1 – 10 μL

1 – 10 nL

10 – 100 pL

Load

Vol.

[16]

burgeoning miniaturized (microchip) platform is even more attractive as front-end
sample processing (e.g., PCR cycling), back-in signal read-out and electrophoretic
sorting abilities can be combined onto a single wafer creating a micro-total analysis
system (µTAS), also referred to as a lab-on-a-chip [25].
1.5.1 Microfluidic Devices (Detailed microchip genotyping applications provided in
Chapter 2)
Microfluidic devices, commonly referred to as microchips, were first used as
electrophoretic platforms in the early 1990s and they were fabricated with glass and
silicon substrates because their surface properties and optical clarity were essentially
identical to capillary tubing [26].

Recently, polymeric (plastic) substrates having

manageable surface chemistries and adequate clarity have gained favor due to their
relative low cost and ease of machining, which further enhances the outlook for the
aforementioned development of µTAS units [27]. Replicates of plastic microchips can
be mass-produced from a metal mold master containing raised micro-features

Figure 1.9. (Left) Schematic of a “twin T” microchip typically used for electrophoresis.
(Right) A x100 magnified image of microstructures hot-embossed in a plastic substrate.
[17]

(channels) by injection molding or hot-embossing into an amorphous substrate (see
Figure 1.9) [28].

Figure 1.10. Microchip sample loading and corresponding voltage applications through
a twin T injection zone and the initial separation of the volume-defined sample plug.

Electrophoretic separations carried out on microfluidic devices are similar in
manner to those performed using a capillary. The major operational difference lies in
the sample plug introduction prior to separations. Capillary injections involve placing a
tube in a sample vial and electrokinetically pumping sample into it over some given
period of time, and then returning the capillary to a system buffer vial to perform
separations.

Alternatively, microchip injections are performed by electrophoretically

attracting a sample placed in an on-chip reservoir across a separation channel, at which
point the sample volume within intersecting zone – the sample plug – is simultaneously
electrophoresed as the residual sample is drawn back into the sample reservoir (see
Figure 1.10). Unlike capillary injections, microchip injections do not suffer electrokinetic
[18]

injection biases whereby smaller charged species are loaded onto a conduit in larger
quantities than larger, slower moving charged species, thus leading to unrepresentative
sample loading, particularly for DNA samples [29].
1.6 Research Focus
In the following chapters of this dissertation, the research efforts conducted to
advance the development of genetic analysis methods on polymer microchips will be
described. The focus of this work was the adaptation and transition of DNA mutation
product separations currently limited to CAE system processing onto inexpensive
polymer microchips manufactured by our research group. These separation adaptations
included two novel enzyme-based genotyping methods having high fidelity for correctly
identifying known and unknown mutations present in low abundances; the ligase
detection reaction (LDR) and endonuclease V – ligase detection reaction (EndoV/LDR)
assays, respectively. The purpose of this work was to set the stage in part for the future
completion of disposable µTAS units suitable for clinical genetic analyses.
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Chapter 2: High Resolution DNA Separations Using Microchip Electrophoresis
for Genotyping Applications*
2.1 Introduction
The completion of the Human Genome Project (HGP) approximately 50 years
after the discovery of the DNA double helix has unveiled a multitude of genetic
information, which will and has begun to shape future directions in biomedical research
and others as well. For instance, we now know that the sequences of human genomes
are nearly 99% identical and that our genome contains only approximately 30,000 –
40,000 genes instead of the hypothesized 100,000 (one gene per protein), leaving
about 1% of the human genome that codes for functional components that regulate
various cellular machinery and processes.

However, this small percentage of the

human genome accounts for over 90% of all sequence variations that make each
individual unique [1, 2]. Aside from the discovery of the remaining unidentified genes,
the challenge that now remains is identifying (genotyping) the subtle differences within
various regions of the genome known as polymorphisms that are produced from either
environmental or inherited conditions and can be linked to a number of diseases. Most
polymorphisms are classified as single nucleotide polymorphisms (SNPs) in which a
single base is substituted, which can potentially lead to genetic mutations and thus, the
development of deleterious conditions such as sickle cell anemia, muscular dystrophy
and many forms of cancer to name just a few.
The undertaking of unraveling the primary structure of our genome (DNA
sequencing) or looking for unique sequence structural differences within the genome
(DNA genotyping) has driven the advancement of DNA-based electrophoretic
technologies significantly beyond the performance metrics that could be realized using
slab gels, which were the dominate electrophoresis platform used up until the late
*

Reprinted with permission from the Journal of Separation Sciences. [22]

1990s.

In order to relieve the labor intensive demands associated with slab gels,

automated high throughput formats of gel electrophoresis were required to meet the
demands predicated by the HGP.

This was satisfied to a certain extent with the

development of capillary array electrophoresis (CAE).
To further reduce the time and overall cost of DNA analysis, planar microfluidic
devices have been projected as a viable alternative electrophoretic platform. This has
lead to the production of a few commercial instruments using glass microchips instead
of capillaries or slab gels, which have been discussed elsewhere in detail [4]. In Table
2.1 is provided a basic operational and performance comparison between the 3
electrophoretic platforms typically used in DNA analysis namely, slab gel, CAE and
microchip electrophoresis (microchip CE).
Table 2.1. Performance and operational comparison between three different
electrophoresis platforms used for DNA sequencing.
Number Injection Analysis Avg. Field
Through- Gel
Lane
Of
Volume Time
Read- Strength* put
Pouring Tracking
Lanes
(nL)
(h)
length (V/cm)
(bases/
(bp)
per 8 h)
Slaba
96
500 6 -8
700a
20-50
67,200
Yes
Yes
gel
1,000
Capillary
96b
1-5
1-3
650b
100-300 ~166,400b
No
No
c
c
Microchip
96
0.1-0.5
0.1-0.5
430
100-300 ~660,480c
No
No
a) ABI 377A [73].
b) based on ABI 3730xl using standard sequencing conditions [74].
c) based on research from [65].

As seen from the data presented in Table 2.1, CAE and microchip CE offer some
attractive capabilities, such as the elimination of gel pouring and lane tracking due to the
boundary conditions imposed on the separations by the walls defining the separation
channel. In addition, the small diameter of the separation columns utilized in these
micro-separation platforms permit the use of higher electric field strengths to
[23]

significantly reduce electrophoretic development time. As a result of the performance
capabilities associated with these micro-column separation platforms, they can improve
throughput compared to slab gel electrophoresis by nearly 3-fold for the CAE format,
but by nearly an order of magnitude for microchip CE. The challenge with the microcolumn separation techniques is that they require load volumes that are 3 – 4 orders of
magnitude smaller than slab gel electrophoresis and as such, place severe demands on
detection and/or sample pre-processing prior to the separation to build sufficient
concentrations of the targets for detection.
In this post-genomic era, DNA separation-based technologies are shifting from
primarily a research tool into a more diffuse user pool targeting such as clinical
diagnostics, forensic applications, and small-scale sequencing of individual genomes for
personalized medicine initiatives.

To realize this transition, DNA-based analysis

systems must attain certain performance characteristics such as: (1) Development of
low cost instrumentation that can be easily operated by novice users. Typically, the
equipment required for processing DNA samples is expensive, difficult to operate and
maintain and performs only one step of the many steps that are required for DNA
processing. For example, many of the CAE-based electrophoretic instruments require
expensive laser systems for reading fluorescence from the capillary tube(s) in a finish
line format, gel sieving matrices that are expensive that must be changed after every
single electrophoretic run and finally, perform only the separation step. DNA samples
typically require significant amounts of pre-processing prior to the electrophoresis such
as purification, amplification via PCR, and labeling of the generated DNA fragments.
Unfortunately, different instruments are required for each step of the processing
pipeline, which significantly increases the capitol equipment costs for performing genetic
[24]

assays as well as demanding high levels of operator expertise. (2) Automation of the
entire DNA processing pipeline preferably into a single instrument. As noted above, the
analysis of DNA typically requires many processing steps, with each step dedicated to a
different instrument.

This requires manual handling and transfer of samples from

instrument-to-instrument, which leads to contamination, sample loss and potential errors
in reporting answers from assays in which the copy number of the input DNA is low. (3)
Disposable fluid handling devices that can be mass-produced at low-cost. The
containers or reactor vials for the sample must be discarded after a single use to
prevent sample carryover from one assay to the next potentially giving rise to false
negatives, which is critically important in such areas as DNA diagnostics and DNA
forensics. At the present time, titer plates are used for sample containment, which are
then poised on instruments that carry out the required active processing such as
thermal cycling reactions. In the case of the electrophoretic sorting step, the processed
samples (typically 96 – 384) are either pipetted into a well of the slab gel or
electrokinetically injected into an array of glass capillaries. The slab gel is used once
and discarded while capillaries are flushed after a single use and filled with fresh sieving
matrix.
Microfluidic chips hold the potential to allow expansion of DNA-based assays into
a broader application base due to their ability to directly address the 3 issues cited
above.

For example, microfluidic chips can be constructed from moldable polymer

(plastic) materials to fabricate monolithic devices that are not only potentially low-cost,
but can be populated with many of the processing steps required for DNA analyses on
the same chip used to carry out the electrophoretic separation. This can create

[25]

functional platforms that provide high levels of automation at low cost and reduce the
number of peripherals (i.e., instruments) built around the intended application.
Early microfluidic efforts were focused on developing devices specifically for the
electrophoretic step of DNA analyses and used predominately glass-based devices.
This was spawned by glass’ high optical clarity, which accommodated nicely to optical
fluorescence readout, and surface properties that were similar to that of capillaries,
which allowed simple transitioning of many of the surface chemistries from capillarybased instruments to microchips.
In the past few years, many polymeric materials have been extensively evaluated for
their potential use as micro-electrophoretic devices and several have been found to
possess favorable qualities [5].

Besides the lower cost of the material, the

manufacturing methods now available to produce plastic microfluidics allow for much
faster production and at lower cost to meet the anticipated demands imposed by the
clinical and forensic markets. However, it should be noted that many of the established
surface chemistries that have functioned well for glass or fused silica, such as the
dynamic coatings used to suppress the electro-osmotic flow (EOF) or minimize solutewall interactions, do not transition well to polymer-based devices due to profound
differences in surface chemistry. In addition, the optical clarity of many polymers does
not compare favorably to that of glass or fused silica, especially in the UV and/or visible
region of the electromagnetic spectrum [4].
In this review, we will focus specifically on recent progress made in the area of
microfluidic chips for electrophoretic-based genomic analyses including genotyping,
DNA sequencing, and forensic applications. For reviews that cover a variety of different
biological applications of microchips we would refer the reader to [6-10]. In addition, for
[26]

reviews that have focused on the integration of various DNA pre-processing steps into
the micro-separation chip, several reviews have appeared in which the reader can refer
[11, 12]. The areas that we will discuss include genotyping applications (mutation
scanning and mutation detection) for diagnostics, DNA forensics and finally, DNA
sequencing.
2.2 Genotyping: Mutation Scanning Applications
Mutational scanning strategies are used to search for sequence polymorphisms
in which the locus or location of the polymorphism is not known or the sequence
variation occurs sporadically within a certain section of the genome. Common scanning
techniques that are used in conjunction with electrophoresis to type DNA include singlestrand conformation polymorphism (SSCP), heteroduplex analysis (HDA), denaturing
gradient gel electrophoresis (DGGE) and temperature gradient gel electrophoresis
(TGGE).

These methods are based on conformationally-induced mobility shifts of

Watson-Crick matched or mismatched single or double-stranded DNA (dsDNA)
fragments and represent an alternative to DNA sequencing, which is still impractical for
routine clinical uses due to its relatively high cost, labor-intensive processing and slow
turnaround time. Moreover, scanning methods have the ability to score DNA regions
containing large insertions and/or deletions. Genomic interrogations of this sort are
typically used for the detection of unknown SNPs within PCR amplified regions;
however, vital information regarding the exact sequence location and characterization of
SNPs are not rendered using most mutation scanning assays. With the exception of
DGGE, all of the methods described above have been adapted to a microfluidic format.

[27]

2.2.1 SSCP
SSCP is widely applied for DNA mutation scanning due to its relative simplicity
as only PCR amplification and subsequent denaturation of the double-stranded
amplicons to generate single-stranded DNA is required for sample preparation prior to
the electrophoretic sorting.

Single-stranded DNA fragments, under the appropriate

experimental conditions, possess sequence-specific 3-dimensional conformations
resulting from intra-strand base pairing. Heterozygous alleles have the exact same size
as homozygotes, but possess one or more altered bases at loci that can be scored
through conformationally-induced perturbations to the electrophoretic mobility. Samples
subjected to mutation scanning surveys using SSCP, and all mutation scanning assays
for that matter, typically include the mutagenic DNA as well as their known wild-type
counterparts from a PCR-defined region. As such, the electrophoretic technique must
be able to afford high resolution capabilities to observe the presence of the mutation in
a high level of background from “normal” or wild-type DNA sequences.
Closely following the formats adopted for SSCP analysis using slab and capillary
gel electrophoresis (CGE), researchers have established microfluidic separation
methods for SSCP. For example, the first published research exploring SSCP on a
microchip was by Tian et al. who displayed the usefulness of this platform to distinguish
three common mutations in BRCA1 and BRCA2 genes (185delAG, 5382insC, and
6174delT) among the Ashkenazi Jewish population, which possess high risk for breast
cancer. Their glass microchip profiling methodology, which paralleled a CGE method
that was also presented in the report, used 2.5% hydroxyethylcellulose (HEC)
containing 10% glycerol as a sieving matrix, which discriminated all mutant alleles from
their wild-type counterparts with a four-fold reduction in analysis time (~130 s)
[28]

compared to the CGE separation [13]. However, they noted a substantial decrease in
resolution in the microchip SSCP profiles and attributed it to possible inadequate
surface passivation of the microchip using polyvinylpyrrolidone (PVP) as the dynamic
coating for EOF suppression and a lack of adequate temperature control in the
microchip format.
As with the case of SSCP analysis employing capillaries, the most scrutinized
aspect of microchip SSCP separations remains the selection of appropriate separation
parameters to impart large mobility differences for subtle sequence variations such as
the type of sieving matrix, stability of the additive, wall coatings, temperature, and field
strength. As such, parametric studies placing emphasis on these parameters have
recently emerged.

For example, Endo and co-workers presented a systematic

optimization of SSCP separation conditions using a glass microchip, which they
ultimately used to probe for a set of seven p53 mutations. Evaluating a wide array of
sieving and glycerol concentrations, they found 1.5% methylcellulose excluding glycerol
to be the most effective sieving matrix as the two commercial systems used (Agilent
2100 Bioanalyzer and Hitachi SV1100) did not possess microchip cooling capabilities to
attenuate the Joule heating produced when glycerol was present [14].

Using the

optimized set of sorting parameters, the authors were able to analyze the full panel of
markers in under 1 min. Kang et al. used another sieving combination (1.75% PVP,
1.0% poly(ethyleneoxide), 5% glycerol including 0.01 - 0.025% NaOH) to enhance
selectivity of SSCP profiles for ghrelin (childhood obesity-related) Leu72Met point
mutations using commercial glass microchip-based instruments [15]. They were able to
resolve the full panel of markers using the aforementioned microchip conditions in under
85 s. A high-throughput SSCP analysis of genes associated with hereditary
[29]

hemochromatosis (metabolic iron storage disorder) and hypertrophic cardiomyopathy
(heart muscle abnormality) has also been demonstrated using a 48-lane section of a
384-lane glass-based microdevice, which yielded 100% selectivity for the 21 mutations
being scanned [16]. The 200 mm diameter high density microchip contained 8.0 cm
length straight channels that were radially-configured about a centered common anode.
In this study, they performed separations in their preferred sieving material (5.0%
polydimethylacrylamide, PDMA, 10% glycerol, 15% urea) at two running temperatures
(25ºC and 40ºC) to realize full separation of the marker panel. The authors also noted
that using a delayed back biased electrokinetic injection scheme improved sample
loading resulting in higher plate numbers and improved resolution.
2.2.2 HDA
HDA is an electrophoretic mutation scanning method that is based on relative
conformational changes between heteroduplexed and homoduplexed PCR amplified
DNA fragments. This method differs from SSCP because it relies on differences in
conformational structures of nearly complementary (heteroduplexed) and completely
complementary (homoduplexed) double-stranded DNA (dsDNA) fragments instead of
single-stranded intra-molecular folding as is used in SSCP. Formed heteroduplexes
contain bulges within the rehybridized DNA fragments where bases are mis-matched
and are typically accompanied by an abundance of homoduplexes that possess
hybridions that are fully matched (i.e., no bulges). When electrophoresing a mixture of
homoduplexes and heteroduplexes using the appropriate separation parameters, slight
mobility shifts between these species are often observed. This method is often used for
DNA species containing insertions and deletions, which typically yield more pronounced
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mobility shifts due to significant bulges resulting from mismatched base pairs in
duplexed DNA.
Tian et al. first brought attention to the potential of microchip HDA separations for
differentiating

six

different

heterozygous

breast

cancer

associated

mutations

(185delAG, E1250X (3867GT), R1443G (4446CG), 5382insC, 5677insA and 6174delT)
within BRCA1 and BRCA2 genes. This was one of the first reports of HDA separations
in which the microchip CE method was directly compared to CGE formats [17].

The

authors found a four- to six-fold reduction in analysis time for the microchip trials using
the same buffer and sieving reagents as that used for CGE (1xTBE buffer with 15%
urea, 2.5% and 4.5% HEC with 10% glycerol).

The reduced analysis time was

associated with the use of an effective separation distance for the microchip (5.5 cm)
that was shorter than that used for the CGE format. However, this separation channel
length was insufficient to provide the same level of resolution incurred with the capillary
columns.
Another microchip-HDA study involving the detection of five BRCA1 and BRCA2
mutations was conducted and directly compared to a denaturing (d)-HPLC method [18].
These authors found that while the glass microchip separations could not approach the
remarkable selectivity provided by (d)-HPLC, the microchip method could provide more
information on different mutations within the same amplicons. Moreover, the authors
emphasized the microchip’s operational advantages including simplicity of the
separation protocol, versatility and lack of sample preparation constraints.
Due to the similarities in the electrophoretic conditions used for HDA and SSCP,
separations of various DNA species can be performed using both HDA and SSCP
simultaneously. The complementarity of the two is often advantageous in circumstances
[31]

when the selectivity of one is inadequate to score the presence of the full panel of
potential mutations. Therefore, most adaptations of these techniques on microfluidics
have been performed in a tandem format. The first microchip-based HDA-SSCP report
of this type was given by Vahedi et al., who described an integrated on-chip labeling of
HFE and BRCA1 amplicons with fluorescent dyes prior to separation of the
complementary species using a commercial polymer [19].

A similar integrated

microchip-based HDA/SSCP approach by Manage et al. was reported with the
exception of the on-chip labeling scheme as noted for the Vahedi et al. report [20]. The
authors detailed the profiling of three specific HFE mutations having high clinical
relevance (C282Y, H63D, and S65C) for hemochromatosis. The separation required a
4 min electrophoresis development time using microchip CE. An exhaustive study to
elucidate the optimal parameters for glass microchip CE analyses using a combined
HDA/SSCP method was conducted by Hestekin and co-authors [21]. They found that a
combination of 8% w/v 600 kDa LPA and a dynamic wall-coating of poly(Nhydroxyethylacrylamide) as opposed to a wall coating using covalent methods provided
the best performance for p53 conformer separations, which could be completed in less
than 10 min of electrophoresis development time.
Diverging from the use of a combined HDA and SSCP approach, an integrated
on-chip HDA/restriction fragment length polymorphism (RFLP) methodology was
demonstrated. Footz et al. demonstrated the discrimination of both heterozygous and
homozygous mutations present in the HFE gene using microchip electrophoresis, which
the HDA method alone was incapable of detecting [22].
To date, all HDA-related assays have been conducted on glass-based
microchips.

For clinically-based assays that require one-time or disposable use
[32]

devices, transitioning these mutation-scanning electrophoresis assays to polymer-based
chips will be critical, since polymer devices can be produced at lower cost in higher
scale production modes compared to glass chips.
2.2.3 TGGE and DGGE
TGGE and DGGE are two analogous techniques used to discriminate
heteroduplexes containing mismatched base pairs from fully matched homoduplexes by
continuously altering the temperature or chemical denaturant conditions in a gradient
format during the migration of solutes through the separation channel, which affects the
degree of dsDNA conformational stability throughout the separation process and as
such, perturbs electrophoretic mobility. Here, denaturing of the dsDNA is induced either
by heating (temperature, TGGE) or imposing linear increases in chemical denaturing
agents within the sieving gel (denaturing, DGGE) to affect the separation. While it has
been difficult to translate DGGE from the slab gel to micro-separation formats due to the
inability to introduce heterogeneous denaturing conditions into the gels for the microseparations, TGGE has proven to be more amenable to these separation platforms,
especially microchip CE, because of the ability to fabricate heating elements along the
length of the entire separation column.
Buch et al. used a 10 channel polycarbonate (PC) microfluidic device out-fitted
with external bulk heaters or internally tapered micro-heaters to induce spatial and
temporal temperature gradients along the length of the separation channels for gelbased sorting of G-C rich dsDNA fragments generated from a primary PCR. Comparing
the two heating configurations, they found that the integrated micro-heaters provided
better thermal response time and more accurate control, producing better TGGE
separations [24].

This same group later introduced a mutation scanning network
[33]

consisting of an integrated two-dimensional micro-electrophoretic platform, which
combined a standard size-based gel electrophoresis separation in the first dimension
with TGGE in the second dimension [23]. This device, which is shown in Figure 2.1,

Figure 2.1. Illustration of the temporal temperature control setup used for microchip
TGGE. The microchip in this case was made from polycarbonate (PC). Reprinted with
permission from [23].

was made from PC with external bulk heaters used to establish the temperature
gradient along the TGGE channels. An intermediate sample stacking strategy was
implemented as well to reduce band broadening during sample transfer between the
dimensions. The 2-D separations of multiplexed SNPs varying in size and sequence
were conducted in a development time of less than 5 min with the prerequisite
resolution to observe all of the SNPs [23].

[34]

2.3 Genotyping: Mutation Detection Applications
Unlike the mutation scanning techniques previously discussed, mutation
detection methods are geared toward the identification and detection of particular
genomic variations in which the locus is known within a certain gene. Most assays
associated with this class of mutations involve the use of nucleotide recognition
enzymes including endonucleases, exonucleases, and thermostable ligases, which
specifically cleave or bond DNA sites that harbor the mutation being interrogated.
Several of the mutation detection assays that have been utilized for the
identification/detection of point mutations or SNPs include allele-specific PCR (ASPCR), restriction fragment length polymorphism (RFLP), ligase detection reaction
(LDR), ligase chain reaction (LCR) and single base extension assays (SBE), all of which
depend on a high resolution electrophoretic step to sort the generated products in order
to score the presence or absence of the mutation of interest. Most of these types of
assays require DNA primers that hybridize to particular locations within the genome,
which harbor the mutation being interrogated, prior to the enzymatic reaction and as
such, require knowledge as to the specific location of the mutation in order to design the
appropriate sequences in the primers.
2.3.1 Allele-Specific Polymerase Chain Reaction (AS-PCR)
While PCR is an attractive method to amplify target DNA sequences of interest
prior to secondary treatments such as electrophoretic analyses, the successful
generation of PCR amplicons can be directly interrogated for scoring the presence of
SNPs based on the use of sequence-specific primers for the PCR that are generated for
the locus or loci being interrogated.

For example, if the PCR primers possess a

mismatch with the target DNA, the amount of PCR product can be significantly reduced
[35]

or even eliminated by proper selection of the annealing temperature used in the 3-step
thermal

cycling

process

associated

with

PCR

compared

to

fully

matched

primer/template duplexes. Therefore, the electrophoretic sorting of PCR amplicons can
be used to detect the mutation of interest by preceding the electrophoresis with a PCR
step. Challenges in AS-PCR include the need for tight control on the design of primers
and understanding their annealing temperatures (Tm), the inability to highly multiplex the
assay and the difficulty in securing quantitative information due to the non-quantitative
nature of most PCR-dependent assays.
Huang et al. selected to separate gastric cancer-related SNPs using a microchip
CE system to complement a simple-tube genotyping method, which combined a whole
blood PCR with a tetra-PCR in which the PCR was conducted directly from 1 µL of
unpurified whole blood or paper-dried blood [25]. Three typical genotypes of the two
SNPs probed (IL-1B-31 and IL-1B-511) within the IL-1B gene were obtained in a 2 min
analysis time using a commercial microchip system with its appropriate gel matrix
(Agilent system).
Sung et al. demonstrated the use of PMMA microchips to perform fast exclusion
tests via PCR product profiling of fragile X syndrome (FXS) alleles based on their
repeating unit size, (CGG)n, within the familial MR type 1 (FMR1) gene [26]. Using wire
imprinted or hot embossed PMMA microchips filled with 1.3% or 1.8% hydroxyl
propylmethyl cellulose (HPMC) containing an intercalating dye (TOPRO-3) to enhance
detectability, they found that PCR bands with more than six unit repeat differences
could be resolved in less than 3 min using a 6 cm electrophoretic separation length.
Low-density lipoprotein (LDL)-receptor gene microsatellite alleles of the D19S394
tetranucleotide repeat associated with familial hypercholesterolemia were sized using
[36]

an Agilent 2100 microchip system [27]; 17 alleles were easily distinguished using
microchip CE, which varied from 0 – 17 repeats. Likewise, the same instrumentation
was used by Sohni et al. to perform routine separations for a host of PCR-amplified
variable number of tandem repeats (VNTRs) markers indicative of diabetic and
cardiovascular complications stemming from irregularities in several genes [28]. A 12lane microchip was used to detect spermatogenetic failure in a multiplexed format
following an offline multiplexed PCR of three DNA sequence-tagged sites of interest on
the Y chromosome [29]. With all of the required components resolved using a 1.5 cm
effective separation channel, 36 samples could be processed within 180 s.
A PCR study of p16 tumor suppressor gene inactivation via hypermethylation
was also evaluated on a microchip using AS-PCR. Comparing the ability of slab gel
and an injection molded PMMA microchip to resolve methylation-specific PCR
amplicons from 153 DNA plasma and tissue specimens including positive and negative
controls, Zhou et al. found that the microchip separations yielded a 26.6% higher
positive rate while maintaining specificity equal to that of slab gel electrophoresis [30].
While fluorescence detection schemes are primarily used for DNA genotyping
analyses due to its high sensitivity and low limits-of-detection as well as the ease of
labeling fragments using fluorescently-tagged primers required for the PCR step, an onchip electrochemical detection strategy has also been introduced that was capable of
detecting PCR amplicons [31]. By modifying a screen-printed carbon electrode, which
effectively lowered the detection potential and reduced electrode fouling, unlabeled
human heat shock factor (HSF1) gene amplicons were electrophoresed in a sieving
matrix comprised of HEC at an optimal field strength of 200 V/cm and were detected
with the screen-printed carbon electrodes. Some representative results from this study
[37]

are shown in Figure 2.2. The assay possessed a detection limit of 584.3 fg/µL (±1.3
fg/µL).

Figure 2.2. Elelctropherograms for the separation and detection of DNA fragments
present in the BIONEER 1 kbp DNA standard marker (concentration = 130 ng/mL). The
detector consisted of a modified screen-printed carbon electrode (A). The surfaces of
the carbon electrodes were modified with poly-5,2'-5',2''-terthiophene-3'-carboxylic acid,
which improved the analysis performance by lowering the detection potential.
Electrophoretic results with electrochemical detection of 30-cycle PCR products at a
bare (B), and modified (C) screen-printed carbon electrode. The standard marker
consisted of 500, 1000, 1610, 2000, 2961, 4025, 5007, 5991, 8029, and 10 200 bp
fragments. The detection potential used was 10.8 V (vs. Ag|AgCl reference electrode).
Reprinted with permission from [31].

Besides routine testing for endogenous genetic conditions of individuals for
clinical diagnostic/prognostic applications, PCR-based approaches for the detection of
deleterious bacterial and viral infections affecting humans have also been subjected to
electrophoretic analysis using microchip CE. For example, Kaigala et al. developed a
hybrid microfluidic system for the production, detection and quantification of PCR
products from the BK virus (BKV), a renal dysfunction highly associated with
[38]

transplanted kidney rejection [32].

Integrating PCR and separation processes onto

PDMS-glass hybrid microdevices, they were able to detect as few as 1 – 2 viral copies
as well as gauge the overall viral loads of clinical samples from renal transplant
patients.
Chen et al. utilized wire-imprinted PMMA microchips to screen for hepatitis C
present in blood serum of symptomatic patients and reported the completion of
separations one order of magnitude faster than CGE [33]. In another study, fabricated
PMMA microchips were also used to probe for SARS and hepatitis B virus (HBV)
samples of known infected patients [34]. The device, containing trapezoidal imprinted
channels transferred from a silicon master, reportedly yielded detection rates of 94.4%
(17/18) and 80.6% (29/36) for multiplexed PCR SARS and HBV samples, respectively.
Karasawa et al. performed microchip CE separations to detect cariogenic (tooth
decaying) bacteria in dental plaque [35].

In this case, AS-PCR was performed to

amplify S. mutans and S. sobrinus, both known to promote tooth decay when they
coexist in plaque. Comparing several mixtures of polyethylene oxide (PEO) and HPMC,
they found 0.125% HPMC/0.6% PEO to provide the optimal mesh for the given
amplicon sizes (202 and 226 bp, respectively). The separation of the two species was
carried out in ~ 85 s on commercial Hitachi injection molded PMMA microchips.
2.3.2 PCR/Ligase Detection Reaction and Ligase Chain Reaction (LDR and LCR)
LDR is a mutation detection assay that involves the use of two complementary
primers designed to flank a polymorphic site within the target DNA. One primer is called
the discriminating primer and contains the polymorphic site on its 3’ end with the allelic
content either matching or not matching the polymorphism on the target DNA. The
other primer, called the common primer, is phosphorylated at its 5’ end.
[39]

Upon

hybridization of these primers to the target DNA, a highly specific thermostable ligase
seals them only if there is a complete match between bases on the 3’ end of the
discriminating primer and the polymorphic locus on the target DNA. If successful ligation
does occur, it generates an elongated and fluorescently labeled oligonucleotide that can
be distinguished from excess labeled unligated primers through differences in their
sizes using electrophoretic sorting [36]. This assay is attractive because it decouples
the PCR from the mutation detection reaction, which provides high specificity, it is
amenable to multiplexing and it also performs exceptionally well in the presence of high
levels of wild-type targets. The challenge associated with this technique rests not on
the reaction itself, but with the ability to adequately resolve, via electrophoresis, several
short single-base differentiated oligonucleotides (<100 bp) from the labeled and
unligated primers that can potentially mask the positive signals indicative of the
mutations due to their much higher concentration when the copy number of the mutated
DNA is low compared to the wild-type sequences. Therefore, highly viscous polymers
(8-10% polyacrylamide) are typically required to provide baseline resolution of all
components generated from the LDR assay.
Thomas et al. demonstrated the ability to use a hot-embossed PMMA microchip
filled with a 4% LPA or other commercial polymers for the analysis of a 12.2 K-ras LDR
product (44 bp), indicative of a mutation that could be associated with the onset of
colorectal cancer [37].

The results secured from the microchip CE result were

compared to those using a conventional CGE format using a 4% LPA gel.

CGE

analysis of the LDR samples was incapable of providing reliable results due to
electrokinetic injection biases; the higher concentration of the LDR primers as well as
their higher mobility prohibited sufficient injection of the generated LDR products,
[40]

especially when the wild-type DNA was >100 fold higher in copy number compared to
the mutant DNA.

The microchip CE format performed much better under these

conditions due to the absence of electrokinetic injection biases when adopting a cross-T
injection format. The microchip CE separations of LDR products possessing a 100-fold
molar excess of wild-type targets clearly showed the presence of the low copy number
mutant alleles (well-resolved from the intense primer peaks) and required a
development time of ~120 s in a separation channel length of only 3.5 cm [37]. In
addition, the authors demonstrated that desalting prior to electrophoretic separation
using microchip CE was not necessary as it was in the case for CGE.
The LDR assay, which is carried out with temperature cycling (denaturing and
annealing) to linearly amplify the number of generated products, is often times coupled
to a primary PCR in which the PCR is used to amplify the gene of interest, which can
contain severe loci harboring the mutations of interest. PCR and LDR have been
successfully integrated onto a polymeric microfluidic device, that can be used to
generate products for subsequent interrogation using microchip CE [38]. The reaction
time of the coupled PCR/LDR was reduced to 6.5 min as opposed to 1.5 h required for
conventional benchtop thermal cycling instrumentation.
LCR is also a SNP detection method, which is based on the ligation of two pairs
of oligonucleotide primers that hybridize to adjacent positions on complementary strands
of a target dsDNA. Similar to PCR, LCR exponentially amplifies target sequences,
however, LCR differs from PCR because it amplifies only the generated probe molecule
(ligated primers). Moreover, LCR has been found to be more specific than PCR in
some cases, which is prone to amplifying false positives occurring in early cycling
events [39, 40]. The products of this application have also been detected and quantified
[41]

following electrophoresis on a microfluidic device. In a study highlighting the effect of
polymers to dynamically passivate silicon-glass microchips, Lou et al. demonstrated the
ability to resolve LCR products of NOD2/CARD15 genes related to inflammatory bowel
disease using microchip CE [41].
2.3.3 Single Base Extension (SBE)
SBE, also known as minisequencing, has emerged as an effective mutation
detection technique to determine the allelic composition at a particular locus; it is
considered attractive due to its simplicity as only a few major components including a
primer, polymerase and a nucleoside triphosphate substrate are required to conduct the
assay [42]. Moreover, the total development time of reactions is considerably short
compared to most typing methods in terms of those requiring thermal cycling [43]. SBE
reactions entail annealing a primer one base removed from the locus containing the
SNP to a particular DNA template. Following hybridization, fluorescently-labeled
dideoxynucleotides are added to the reaction and the appropriate dideoxynucleotide is
added based on the allelic composition of the locus being interrogated. The reaction is
similar to conventional Sanger sequencing reactions except that deoxynucleotides are
not included in the reaction cocktail and as such only a single base is added to the
primer [44]. This method has been adapted to various microchip CE systems and the
associated four-color multiplexing detection hardware associated with many CGE
sequencing and genotyping equipment, which allows for spectral identification of the
incorporated dideoxynucleotide. Although SBE in conjunction with conventional CGE
has been extensively used and reported for multiplexed SNP genotyping, few reports
discussing SBE/microchip CE combinations have surfaced, most likely due to the
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stringent separation performance demanded for SBE (single base resolution of short,
~15-20 bp, DNAs).
Vreeland et al. illustrated the novel pairing of SBE with end-labeled free solution
electrophoresis (ELFSE) for genotyping three p53 loci using a commercial CGE system
and discussed the potential of transitioning this strategy to microfluidic platforms [45].
Recently, the Barron group demonstrated the microchip-based separation of
multiplexed reactions to probe 16 p53 loci with 96% accuracy using ELFSE and
microchip CE. With only a denaturing buffer containing a EOF suppressant as an
electrophoretic medium, extension units harboring 16 unique, monodispersed,
uncharged polyamide drag-tags facilitated the size dependent separation of species
within 70 s using a commercial glass microchip [43].
Herbert et al. reported on an electrochemical approach for detecting mock SNP
sites using SBE on a miniaturized platform. The microchip CE device was composed of
a PDMS chip aligned and sealed with a cover slip containing working and reference
electrodes positioned near the channel outlet. Sinusoidal voltammetry was used to
distinguish electrochemically active extension products from unincorporated excess
terminators following electrophoresis through agarose in less than 4 min [46].
2.3.4 Restriction Fragment Length Polymorphism (RFLP)
RFLP relies on the use of various endonucleases, commonly referred to as
restriction enzymes, that cleave recognition sequences usually 4 - 8 bp in length within
dsDNAs. Upon treatment, DNA fragments having unique sizes corresponding to the
distance between the restriction sites cut by the restriction enzymes are generated, and
secondary treatments of the cleaved fragments with other restriction enzymes can
provide further specific fragmentation patterns that can be subsequently subjected to
[43]

Figure 2.3 (a) Reconstructed plot of time versus pixel number of the CCD, which was
monitoring restriction fragments generated across the multi-channel microchip. The
shaded bar represents fluorescence intensity collected by the CCD. The sampling
capillary moved from right to left depositing samples into the chip, so the lane farthest to
the right is designated as lane 1. (b) Schematic of the chip setup with capillary sample
introduction. Laser-induced fluorescence detection was achieved by focusing an argon
ion laser into a line across the chip 5.5-6.5 cm from the injection point. A liquid
nitrogen-cooled CCD was used to analyze the collected fluorescence photons. Adapted
and reprinted with permission from [47].

[44]

electrophoretic sorting. If a mutation or SNP exists at a particular restriction site, it can
change the restriction patterned generated, which can be deciphered using gel
electrophoretic sorting. The limitation associated with this mutation detection strategy is
that the mutation loci must be contained within a restriction site.
A high-throughput microfluidic design has been developed for the continuous
assessment of restriction enzyme kinetics, which have been traditionally conducted
using labor-intensive processing of millisecond-interval quenched enzymatic reactions
and subsequently subjected to slab gel electrophoresis. The device for this application,
as seen in Figure 2.3, used a capillary sampling device to dispense aliquots (1
injection/14 s) from a reaction mixture to a multi-channel (5 channels) glass chip with
the collected fragments separated in the chip using an LPA sieving matrix and detected
via laser-induced fluorescence with a CCD camera [47]. A 62 bp dsDNA containing a
KpnI restriction site was used for system evaluation and the effects of temperature and
restriction enzyme concentration were also examined. The unique aspect of this setup
was that the sampling device (a capillary) was not fixed to the separation platform (the
microchip), and continuous intermittent injections could be processed in the pipeline
without the need for completion of preceding separations, thus increasing throughput.
The ability of microchip electrophoresis to assess restriction digests of samples
containing low percentages of mitochondrial DNA (mtDNA) mutations in blood samples
from diabetic patients was investigated by Guttman et al.

The assay included the

generation of 250 and 251 bp products of a PCR-RFLP treatment designed to include a
known ApaI site responsible for the mutation followed by the electrophoretic sorting of
these products. In glass microchannels filled with a 2% agarose gel containing ethidium
bromide, they were able to routinely discriminate 1 - 2% of A324G
[45]

mtDNA point

mutations in mixtures containing 98 – 99% wild-type levels in less than 12 min [48]. In a
related report, the same author introduced a high-throughput 96-lane format combining
microfibrous

membrane-mediated

DNA

digestion

with

subsequent

microchip

electrophoresis processing. An automated spotter was used to deliver submicroliter
quantities of target DNA and digestion enzymes from 96 well plates onto a membrane,
which served as both a reaction vessel as well as the microchip sample
preconcentration/loading inlet. Results indicated that the digestions were completed
within 1 – 10 min and subsequent separations in the agarose-filled channels (4 cm
effective length) were completed in 5 – 10 min (20 min total analysis time) [49].
Recently, an on-chip treatment of mtDNA employing restriction enzymes was used by
Taylor et al. to differentiate homogeneous and heterogeneous populations of mtDNAs.
The procedure was carried out on a straight channel 8.0 cm commercial glass chip
(Micralyne) and included excising a mtDNA sequence from plasmid DNA via enzymatic
digestion

with

EcoRI

to

linearize

the

plasmid

loops

into

dsDNA

and

denaturing/renaturing to form duplexes of the digested DNA all taking place in a single
sample well. The generated products were labeled with an intercalating dye (sytox
orange) that was present in the separation matrix (Genescan polymer containing 10%
glycerol) during electrophoretic separation (7.6 cm effective separation channel length).
According to the authors, the method could be performed in about 45 min, whereas
conventional methods would require days to perform this same type of assay [50].
2.4 DNA Forensics
The identification of humans based on DNA profiling has become a powerful tool
in the field of forensics. Usually, this profiling is achieved by the analysis of highly
polymorphic variations presented in the form of short tandem repeats (STRs), which
[46]

consist of specific 2-7 base repeating patterns (e.g. (CAGT)n) found in the genome.
Primarily, STRs are distributed throughout non-coding regions of the genome known as
junk DNA with the number of repeating units typically very specific for a particular
individual, especially when occurring at several different loci.
Forensic DNA specimens are commonly matched to alleged criminal suspects in
modern law enforcement using human identification systems validated according to the
DNA Advisory Board’s (DAB) Quality Assurance Standards. These DNA testing
systems typically involve the amplification of highly polymorphic STRs by PCR.
AmpFlSTR® Profiler Plus and COfiler®, Powerplex®, Powerplex-Y, and Y-PLEX™ 12
are examples of commonly used multiplex systems for genotyping polymorphic STRs
residing in the human nuclear (nDNA) and male Y-chromosomal DNA. These analyses
are routinely performed using CGE and the genotyping capability of the ABI 3130
automated

DNA

Sequencer/Genotyper

instrument

within

forensic

laboratories.

However, prior to gel sorting, the DNA sample must be extracted from the specimen,
typically using precipitation-type techniques, purified and then, PCR amplified.
The resulting genetic “fingerprints” are then compared to profiles within the
CODIS (combined DNA Index System) databank to identify a match. The advantage of
these types of analyses lies within the very large number of STR alleles that provide a
very high power of statistical discrimination. When DNA evidence is limited, analysis of
human mtDNA targets is often employed because of the high copy number of
mitochondria and mtDNA molecules in each cell [51].
Forensic DNA testing is also utilized to establish the paternity of children [52]. In
investigative forensics, DNA fingerprinting is used to infer the geographic origin of
unknown human DNA samples [53, 54], to identify potential microbial or viral pathogens
[47]

for bio-defense [55] or to identify species specific source(s) of unknown trace evidence
[56] using PCR-based analysis of a variety of genetic systems including, STRs, single
nucleotide polymorphisms (SNPs) and mobile element insertion polymorphisms.
The key elements of successful STR-typing include both high-resolution
electrophoresis and precise sizing of DNA samples with respect to internal standards
used to identify various alleles within a given locus. The core advantages of microchip
CE in terms of DNA forensics includes the ability to integrate sample pre-processing
steps into a monolithic wafer and the ultra-fast separations afforded by microchip CE,
which could play a vital role in compiling more extensive forensic databases and also,
relieving the backlog of DNA typing cases. For example, the cost, speed and lack of
simple and user friendly equipment available for forensic DNA tests have contributed to
the current backlog of over 350,000 DNA evidence samples from criminal trials.
Work was described by Schmalzing et al. in 1997 using a glass chip possessing
a single channel (45 µm deep and 100 µm wide) to separate single-locus and four-loci
PCR-amplified STRs spiked with allelic standard ladders with a CE development time of
only 30 s and 2 min, respectively, with a 4% LPA matrix under denaturing conditions
over a 2.6 cm effective separation distance [57]. This work was later extended upon by
using a dual wavelength LIF detection approach to increase the multiplexing capacity of
the system to process an eight-loci STR simultaneously in a single separation channel
[58]. A micro-variant allele present in the sample requiring single base resolution was
resolved in 10 min using an 11.5 cm effective channel length appeared in this same
report.
In a subsequent study, the degree of multiplexing was further enhanced using a
four-color excitation/detection system capable of examining 15 loci simultaneously
[48]

within 20 min with single base resolution ranging from 0.75 to 1 [59]. This work lead to
the development of an STR analysis instrument designed around a 16-lane glass
microchip CE device. The chip layout, as seen in Figure 2.4A, included double T cross
injectors for electrokinetic injections in each separation channel and 20 cm effective
separation lengths that converged near the detection point to fall within the range of an
optical scanner. Peak accuracies of 0.4-0.9 bp were reported using the CODIS 13locus multiplex established by the FBI [60].
More recently, plastic microchip CE devices have been assessed for their
potential to accommodate high-resolution analysis of STR samples [61, 62]. In two
related studies, polyolefin substrates having hot-embossed microchannels (4.5, 6.0, 10,
and 18 cm long separation channels) filled with a replaceable 4% LPA matrix under
denaturing conditions were used to electrophoretically sort common STR ladders.
While the 4.5 cm channel was capable of providing single base resolution between
micro-variants [61], higher quality performance was illustrated using the 10 and 18 cm
length channels with a 3% LPA sieving matrix. However, it was noted that pressure
tolerances associated with these devices dictated what sieving matrix concentrations
could be used [62]. Exceeding these pressure tolerances by pumping high viscous gels
through the plastic channel caused release of the cover plate from the chip substrate
and subsequent device failure.
A high-throughput forensic study was demonstrated using a 96-lane microchip
CE device and a 4-color radial scanning detection system. Profiled samples attained
using conventional CGE were analyzed in parallel for comparison followed by the
analysis of several (17) unexamined samples using the 96-lane microchip; microchip
CE provided single-base resolution and runs were completed within 30 min [63]. The
[49]

Figure 2.4.(a) CAD drawing of the chip layout. The design contained 16 lanes with 16
double-T injectors on the right for electrokinetic sample injection. It has a section where
all channels are close together for scanning (arrow), the overall distance at this point is
3.2 mm from injection to detection. (b) Complete assembly with anode on the lower left
and the cathode board on the top right corner; there is a vial for sample inlet and
sample waste for each lane. The effective length of each lane is 20 cm. (c) Computer
screen image of 6-channels of electrophoresis results for the chip system shown in (a).
The electropherograms are from 5 data samples and one allelic ladder. Reprinted with
permission from [60].
[50]

STR typing was accomplished using the PowerPlex 16® and AmpFlSTR® Profiler
Plus® multiplexed PCR systems. Forty-eight previously analyzed single-source samples
were accurately typed, as confirmed by an ABI Prism 310 and/or the Hitachi FMBIO II
CGE instruments. Minor alleles in 3:1 mixture samples containing female and male
DNA were reliably typed as well.
All of the aforementioned microchip-related forensic studies emphasized the use
of STR specifically for human identification. However, in the field of anthropology the
ability to differentiate human remains from those of animals by sampling hair and bone
remnants for mtDNA is sufficient. A recent study has evaluated the usefulness of a
microchip-processed PCR analysis using a commercial system and glass microchip for
probing mtDNA of ancient sources [64]. Highly degraded human and non-human DNA
samples were positively identified using a microchip CE separation by selectively
amplifying target human-specific mtDNA genes (Cytochrome b and 16S ribosomal
RNA).
2.5 DNA Sequencing
Sequencing remains the gold standard for the analysis of DNA in many
applications such as genotyping or DNA forensics in spite of some of its current
limitations, which mainly includes the labor intensive sample pre-processing, the slow
development time and the high performance demands placed on the electrophoresis
phase of sequencing.

The quest to design microchip CE for demanding DNA

sequencing applications as part of the HGP spawned the production of elaborate units
featuring dispersion-limiting channel turn geometries to extend channels within a small
footprint for increased DNA read lengths, offset injection crosses to increase sample

[51]

injection plug volumes to aid in detection and multi-lane formats for high throughput
analyses.
The pioneering report for transitioning sequencing CGE separations to
microfabricated CE chips was presented by Woolley et al. in 1995; the electrophoresis
was conducted on a simple, straight-channel (50 µm wide, 8 µm deep) microchip
channel etched into glass wafers filled with a polyacrylamide gel [65]. With an effective
separation distance of 3.5 cm, four-color DNA sequencing traces of ~150 bp were
performed with 97% base calling accuracy in only 540 s. Improvements upon this work
followed refining subsequent platforms to improve both resolution and throughput.
Ultimately, high density (96-lane) CE microchips with deeper (30 µm) and longer (15.9
cm) effective separation lengths that were radially-configured into a common anode
were developed, which increased the average read length to 430 bases [66]. While this
particular microfluidic device was initially intended for sequencing, it has been utilized in
some of the previously mentioned high throughput genotyping and forensic applications
as well [63].
After

a

stringent

parametric

study of

micro-electrophoretic

sequencing

separations in terms of channel lengths and sieving gel concentrations [67], work by
Aborn et al. introduced an automated microchip CE sequencing system employing 384channel microdevices with channel lengths varying from 37 - 45 cm situated on large
glass plates (25 cm x 50 cm). The device was capable of providing 800 base read
lengths and called 1.72 x 105 bases per 384-lane run with 99% accuracy [68].
Although sparingly reported, plastic-based microfluidics has also been employed
for DNA sequencing. Boone et al. reported four-color sequencing reads of 640 bases
with 98% accuracy using an acrylic microchip bearing an 18 cm embossed channel
[52]

within 30 min [69]. Using polyolefin microchips with much shorter channels (4.5 cm),
Shi et al. demonstrated the ability to read a sequence to 320 bases with 99.1%
accuracy within 13 min [61]. In both studies, replaceable LPA matrices were used for
sieving.
Along

with

the

miniaturized

sequencing

separation

platforms,

auxiliary

components have been incorporated into the microchip CE system to aid in the
separation and detection. For example, Ueberfeld et al. used a solid support sample
loading technique to minimize the obstacles associated with the processing of low
concentrations of DNA sequencing fragments typically encountered using microfluidic
devices (see Table 2.1).

By directly injecting Sanger DNA sequencing samples

reversibly adsorbed onto paramagnetic microspheres and extraction from solution with
a magnetized wire, they were able to achieve fluorescence signal intensities that were
equal to that of standard offset T injectors having >10 times the initial DNA sample
content [70].
Also of interest are efforts in microchip CE for potentially simplifying the DNA
separation phase of the sequencing processing pipeline by developing alternative
electrophoretic separation mechanisms that could potentially eliminate the necessity of
using sieving materials such as polymer gels and their associated high viscosity
constraints.

Using the previously mentioned ELFSE technology [72], ~110 base

sequencing

read

lengths

have

been

reported

using

conventional

capillary

electrophoresis in ~18 min [73].
Researchers are now pushing towards the production of highly integrated
sequencing units to perform sample preparation and cleanup prior to the electrophoretic
separation to minimize the labor and time overhead associated with DNA sequencing.
[53]

Figure 2.5. (a) Photograph of the integrated microchip device, showing one of two
nucleic acid processing systems. Colors indicate the location of sequencing reagent
(green), capture gel (yellow), separation gel (red), and pneumatic channels (blue). (b)
High-quality sequencing data generated using the integrated bioprocessor shown in (a).
Sanger sequencing extension fragments were generated from a 750-bp pUC18 PCR
amplicon. Automatic base calls were secured by the program PHRED and base
numbers are indicated above the electropherogram. Scale bar is 5 mm in (a). Reprinted
with permission from [71].
[54]

Recently, a fully integrated microchip bio-processing unit combining temperature
cycling, sample purification and electrophoretic separation has been fabricated, which
contained nanoliter-scale reaction chambers. Shown in Figure 2.5 is the system, which
consisted of a glass-PDMS hybrid device capable of performing complete Sanger
sequencing on 1 fmol of DNA template with read lengths of up to 556 bases and a
calling accuracy of 99% [71].
2.6 Conclusions
Significant strides have been made toward demonstrating the potential of planar
microchip devices as viable miniaturized electrophoretic platforms for the separation of
DNAs for a variety of different and important applications. Over the past decade,
pioneering proof-of-principle separations of both single-stranded and double-stranded
DNAs as well as enzymatically produced DNA products on primarily glass substrates
have produced highly promising separations that offer the advantages of shorter
electrophoretic development times compared to their slab gel and capillary counterparts
without significant sacrifices in terms of separation resolution.

While progress in

microchip CE separations of DNA samples have been reported, significant advances
and improvements in this technology platform still must be made to allow its permeation
into clinical laboratories for diagnostics and forensic laboratories for DNA typing. For
example, the development of lab-on-a-chip systems that incorporate all of the sample
pre-processing steps into the system incorporating an electrophoretic separation would
provide fully automated analyses with little manual or operator intervention or expertise,
minimize sample contamination and allow permeation of this promising technology
platform into a broader user community.

[55]

Another area that must evolve is significant reductions in the cost of producing
microfluidic chips for CE-based separations and even those chips that consist of
multiple processing steps to allow full automation of the DNA processing pipeline. This
will be particularly important in forensic and diagnostic applications, where disposable
fluidic components are demanded.

Replication technologies of plastic microfluidic

devices can provide an array of ideal fabrication techniques for producing low-cost
electrophoretic and other DNA processing chips. Transitioning glass and fused silicabased techniques to polymeric materials will facilitate the evolution of disposable
microfluidic cartridges for such applications.
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Chapter 3: Capillary and Micro-Electrophoretic Separations of Ligase Detection
Reaction Products Produced from Low Abundant Point
Mutations in Genomic DNA
3.1 Introduction
Electrophoresis can be utilized in screening assays for the diagnosis of
presymptomatic disease states, such as the early detection of cancers, which can arise
from the accumulation of mutations in certain gene fragments that may be inherited or
somatic, caused either from exposure to environmental factors or from malfunctions in
DNA replication or repair machinery. These mutations can then be used as markers in
a variety of different electrophoresis formats, such as heteroduplex analysis, single
strand conformational polymorphism analysis, denaturing gradient gel electrophoresis
or DNA sequencing.
One example where electrophoresis can potentially provide diagnostic
information is the early detection of colorectal cancers using the identification of point
mutations in the human K-ras oncogene, which manifest themselves primarily as single
base-substitutions located at two bases in codon 12, two bases in codon 13 and three in
codon 61. These particular mutations occur in 35 – 50% of all colorectal adenomas and
can manifest themselves early in the development of colorectal neoplasms [1-4]. Once
acquired, these mutations are preserved throughout disease development and thus,
have great utility for diagnostic testing.
Unfortunately, the detection of these mutations is complicated by the fact that
often their presence is masked by significant amounts of wild-type sequences even at
the primary tumor site, which can contain a majority of wild-type stroma. The frequency
of the mutated allele at the primary tumor site can be as little as 15% for heterozygous
samples and this number goes down precipitously if the sampling is done away from
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this site. Therefore, improvements in early detection and treatment of cancer patients
depends intimately on rapid and accurate high throughput methodologies capable of
identifying low abundant mutations with high selectivity.
K-ras mutations may be detected by direct DNA sequencing, allele specific
oligonucleotide hybridization or restriction digestion techniques [5-8]. Others have used
high sensitivity techniques such as phage cloning, allele-specific PCR or repetitive
restriction digestion to detect K-ras mutations in stool or lymph nodes of cancer patients
as indicators of micrometastases [9-15]. Unfortunately, these techniques have intrinsic
limitations, such as low sensitivity (DNA sequencing) or the inability to detect the full
spectrum of K-ras mutations (restriction digestion or allele-specific PCR). Furthermore,
allele-specific amplification techniques are prone to false positives generated from
minute contamination or from the introduction of point mutations by polymerase errors
during extension.
A slab gel-based electrophoretic assay has recently been reported for the
detection of mutations associated with colorectal cancer using a ligase detection
reaction (LDR) [16], a method that simultaneously amplifies DNA and identifies single
base mutations in a multiplexed format [17]. LDR is based on an allele-specific ligation
of two synthetic oligonucleotide primers, which flank the point mutation (a common and
discriminating primer) that hybridize to one strand of the target DNA as shown in Figure
3.1. The junction point of these primers is selected so that the nucleotide at the 3’ end
of the discriminating primer coincides with the single base mutation site in the target
sequence.

The discriminating and common primers are covalently joined to form an

LDR product by a thermostable ligase only if the nucleotide at the potential mutation site
is complementary to the 3’ end of the discriminating primer.
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Figure 3.1. Diagram illustrating the ligase detection reaction and the LDR primer sizes
used for human K-ras gene mutation discrimination at site 12.2 of codon 12 within exon
1. Discriminating primers were fluorescein-labeled on their 5’ ends. The length of the
discriminating primer and the corresponding amino acid abbreviations are indicated; V =
valine, A = alanine, D = aspartic acid.

The process is multiplexed using electrophoresis to screen the full spectrum of
point mutations associated with a particular disease via size discrimination by varying
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the base numbers of the discriminating primer used for the LDR assay as shown in
Figure 3.1 [16]. Generation of an LDR product indicates the presence of a mutation
while the length of the LDR product designates which mutation was present (allelic
composition or mutation location in the gene). In the example shown in Figure 3.1, the
wild-type sequence contains a cytosine (C) nucleotide in the K-ras gene at position
12.2, which codes for the amino acid glycine during translation. Possible mutations at
this site, the resulting amino acid substitution, and their respective abbreviations are
adenine (A) / valine (V), guanine (G) / alanine (A) and thymine (T) / aspartic acid (D).
Thus, a G12V mutation corresponds to a glycine-to-valine change at codon 12 resulting
from a base substitution of G with A.
Using two discriminating primers and one common primer, a slab gel assay was
able to detect one mutation in 4,000 wild type sequences at a 9 to 1 signal-to-noise ratio
[18]. Using an eight-primer set (six discriminating primers and two common primers)
designed to detect two possible mutations in codon 12, the assay was able to detect
one mutation in 1,000 wild-type sequences at a signal to noise ratio of 3 to1. The same
mutation was detected in 500 wild-type sequences using an entire 26 primer set (19
discriminating primers and 7 common primers) designed to probe for 19 possible
mutations at codons 12, 13 and 61 simultaneously. Unfortunately, the slab gel assay
required several hours of electrophoretic development time to adequately resolve the
LDR products from excess unligated primers.
In this paper, we wish to report on the use of capillary and microchip
electrophoresis formats for detecting single base mutations in selected gene fragments
(K-ras) using LDR. Several issues must be considered when developing capillary or
microchip electrophoresis platforms for LDR analyses. In the standard LDR assay, a
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large excess of primer over the target template ensures efficient hybridization and
ligation. Due to the large amount of primers contained within the reaction cocktail, the
electrophoretic method must be able to resolve the LDR product from this excess, both
of which contain a fluorescent label. In addition, single base resolution is required since
the size of the product, as deduced from the migration time, is used to identify the
particular mutation site and/or its allelic composition.
Capillary gel electrophoresis (CGE) can provide a method for the rapid analyses
for LDR-based assays using a variety of different separation matrices to provide
sufficient resolution to detect the LDR product, even at low abundance. However, a
concern associated with this method is the well-characterized injection bias, in which
high mobility species, such as short primers and salts, are loaded preferentially
compared to slower migrating components.

Therefore, high resolution must be

achieved so as not to mask the LDR products in the large band generated from
unligated primers when these are much higher in concentration [19].

In addition,

injection biases can severely limit the loading of the LDR products, demanding high
sensitivity detection as well.

A final concern is the oligonucleotides that must be

separated, which are single stranded DNAs (ssDNA) with a size range <100 bps and as
such, special requirements are demanded for the sieving matrix to provide the
necessary selectivity.
The microdevice format can potentially allow rapid analyses and reduced
consumption of reagents, issues that are important for high throughput screening
applications [20].

Compared to CGE, microelectrophoresis can provide more

representative loading of all fragment sizes through unbiased volume-based injections
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[21]. However, these devices also contain shorter separation lengths that have the
potential to limit resolution unless high resolving power gels are used.
Using a K-ras mutation in codon 12 as a model, capillary and microdevice
electrophoresis methods were developed to demonstrate the ability for analyzing point
mutations in K-ras genes of low abundance with electrophoresis.

Several ssDNA

separation matrices in the capillary and microdevice format were evaluated in a
modeling study using synthetic dye-labeled oligonucleotides for their ability to analyze
low copy numbers of long oligonucleotides (LDR products) in an excess of shorter
oligonucleotides (unligated primers). Using the optimized conditions and separation
matrices in both electrophoretic formats, PCR products generated from cell lines of
known K-ras genotype were used as templates for LDR to detect single base mutations
in codon 12.
3.2 Methods and Materials
3.2.1 Capillary Electrophoresis Instrumentation
CGE separations were performed using a Beckman P/ACE System 5510
(Beckman Instruments, Fullerton, CA).

Data acquisition was performed using the

Beckman P/ACE software. Detection was accomplished using the appropriate laserinduced fluorescence (LIF) module fitted into the CE instrument, which contained an
Argon ion laser (λex = 488 nm) and a 520 nm emission filter placed in front of the
photomultiplier tube.

In all cases, the electrophoresis was performed in a reverse

mode, with the detection end anodic and the injection end cathodic.
3.2.1.1 Capillaries and Sieving Matrices
PAGE-5 (5%T, 5%C) polyacrylamide gel-filled capillaries (referred to herein as
5T5C) and buffer were purchased from Agilent Technologies (Palo Alto, CA). The total
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capillary length was 36 cm while the effective length was 30 cm; however, this length
varied slightly from run to run due to clipping of the inlet end of the capillary prior to
each run to restore column performance.

The electric field strength was set to 250

V/cm at an operating temperature of 25 C. A water pre-injection of 10 s at 10 kV was
used to increase sample loading. Typical injection times ranged from 10 s to several
minutes as indicated in each electrophoretic trace.
The eCap ssDNA 100-R Gel (herein referred to as eCap), buffer and neutrally
coated capillary (75

m i.d.) were purchased from Beckman Coulter (Fullerton, CA).

The optimized separation conditions for the eCap were found to be 308 V/cm at 30 C.
The matrix was replaced in the capillary (30 cm effective length, 36 cm total length) prior
to each run at approximately 800 psi using a pressure vessel designed in-house.
The Performance Optimized Polymer (herein referred to as POP5) and buffer
were obtained from Applied Biosystems (ABI, Foster City, CA).

The optimized field

strength for this gel was determined to be 215 V/cm while the capillary temperature was
set to 50 C. A bare fused silica capillary (75 m i.d., 30 cm effective length, 36 cm total
length) was filled with POP5 using approximately 1,000 psi pressure before each run.
3.2.2 Microdevice Fabrication and Assembly
The microdevice consisted of a 10 cm separation channel with 0.5 cm side
channels to the sample, buffer and waste reservoirs as shown in Figure 3.2A. The
microchannel was hot-embossed in poly (methyl methacrylate) (PMMA) (MSC, Melville,
NY) using a Ni mold master containing microstructures 80

m tall and 20

m wide

(channel dimensions) that were produced by a LIGA process as described elsewhere
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[22]. The final device was assembled by annealing a PMMA cover plate to the open
face of the device at 109 C in a circulating air oven for 15 min.
3.2.3 Laser-induced Fluorescence (LIF) Instrumentation
The LIF microdevice detection system was constructed in-house with an
epillumination configuration, as shown in Figure 3.2B. The system consisted of a 488
nm air-cooled argon ion laser (Omnichrome, Model 532), which was directed to the
focusing objective using a multimode fiber optic and a dichroic mirror. The excitation
beam was focused using a 16X microscope objective (Melles Griot) onto the
microdevice, which was situated on an X-Y-Z microtranslational stage in order to
position the microchannel with respect to the focused laser beam. The fluorescence
emission was filtered though a stack of optical filters and focused onto a single photon
avalanche diode (SPAD, Model SPCM-AQ-141, EG&G Optoelectronics Canada,
Vaudreuil, Canada).

The filter stack consisted of a 520 nm bandpass filter (Oriel,

Stratford, CT) and a 520 nm long-pass filter (Edmund Scientific, Barrington, NJ). The
LIF signals were acquired on a personal computer using a 16-bit counter/timer board
(Model AT-MIO-16XE-50, National Instruments, Austin, TX).
3.2.3.1 Microelectrophoresis Operation
Labview software and an electrophoretic “switch box” constructed in-house were used
to control voltages during the microelectrophoresis. The device included three internal
high voltage power supplies (EMCO) capable of receiving input of 0 or +5 V from DAC
(digital to analog converter) outputs of a PCI-MIO-16XE-50 board (National
Instruments). These power supplies delivered 0 to +2 kV to wells (A) and (B) (EMCO
Model C20); and +0.3 to +5 kV to well (D) (EMCO Model G50) (see Figure 3.2A).
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Figure 3.2. (A) The geometrical layout of the microelectrophoresis chip, which was
fabricated using hot embossing from a Ni master in PMMA. The chip contains four
reservoirs, A = sample; B = waste; C = buffer and D = buffer waste. The chip contained
a separation channel that was 10 cm in total length with a channel width of 20 µm and
depth of 80 µm. (B) Also shown is an annotated picture of the laser-induced
fluorescence system used for detection on the microchips.

During injection, a positive voltage was applied to the waste well (B) (see Figure
3.2A) while the sample well (A) was grounded. During separation, a positive voltage
was applied to well (D), (C) was grounded and “pullback voltages” were applied to the
sample (A) and waste (B) reservoirs to prevent leakage of extraneous material into the
separation channel. The microdevice was first manually filled with separation matrix.
Following filling, the buffer and sample reservoirs were filled with the appropriate
material.

Once filled with the sieving matrix, the gel was pre-conditioned by

electrophoresing for 5 min at 100 V/cm (voltage applied between reservoirs (C) and (D),
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see Figure 3.2A). For the electrophoretic separation, the optimized field strength for the
appropriate sieving gel was used as well as the appropriate pullback voltages on the
sample and waste reservoirs. In all cases, the electrophoresis was performed in a
reverse mode with the injection end cathodic and the detection end anodic.
3.2.4 Modeling Primers and DNA Sizing Ladder
All primers used in this work were obtained from Integrated DNA Technologies
(IDT, Coralville, IA) with PAGE purification and fluorescein labeling of the discriminating
primers at their 5’ ends. The fragments used as models were constructed to mimic
common and discriminating primers as well as LDR products and consisted of 25, 44
and 51 bp fragments of random sequence. Using the 25 base primer to represent the
unligated primers, model samples representing 1:10, 1:100 and 1:1,000 molar ratios of
LDR product to unligated primers were prepared. In each sample, the unligated primer
(25 bp) was maintained at 1.0

M and for the 1:10, 1:100 and 1:1,000 modeling

samples, the 44 and 51 bp synthetic LDR products were 100.0 nM, 10.0 nm and 1.0
nM, respectively.
3.2.5 LDR Primers
Primers used for LDR were purchased from IDT with fluorescein labeling on their
5’ ends (discriminating primer). LDR primers were designed for identification of single
base substitutions in codon 12.2 by altering the length of each primer as shown in
Figure 3.1.

When analyzing the G12V allele, the discriminating primer for G12D was

included in order to monitor potential misligations of the discriminating primer used to
detect the G12D genotype, representing a C:A mismatch in wild-type DNA. The threeprimer set consisted of two discriminating primers and one common primer as shown in
Table 3.1.
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Table 3.1. LDR discriminating and common primers. Primer size and sequence are
indicated. * = common primer, which was phosphorylated at its 5’ end to allow ligation.
Primers

Size

Sequence

Fluor-K-ras c12.2V

26

5’ Fluor-CAA AAA CTT GTG GTA GTT GGA GCT GT 3’

Fluor-K-ras c12.2A

25

5’ Fluor-CAA AAC TTG TGG TAG TTG GAG CTG C 3’

Fluor-K-ras c12.2D

24

5’ Fluor-AAA ACT TGT GGT AGT TGG AGC TGA 3’

K-ras c12 Com-2*

20

5’ pTGG CGT AGG CAA GAG TGC CT 3’

3.2.6 DNA Extraction from Cell Lines
PCR products were amplified from genomic DNA that was extracted from cell
lines of known K-ras genotype (HT29, wild-type; G12V or G12D mutant alleles) [16].
Cell lines were grown in RPMI culture media with 10% bovine serum. Harvested cells
(~1 x 107) were resuspended in DNA extraction buffer (10 mM Tris-HCl, pH 7.5, 150
mM NaCl, 2 mM EDTA, pH 8.0) containing 0.5% SDS and 200 μg/mL proteinase K and
incubated at 37ºC for 4 hr. Thirty-percent (v/v) of 6 M NaCl was added to the mixture
and the samples centrifuged.

DNA was precipitated from the supernatant with 3

volumes of EtOH, washed with 70% EtOH and resuspended in TE buffer (10 mM TrisHCl, pH 7.2, 2 mM EDTA, pH 8.0).
3.2.7 PCR Reagents and Conditions
PCR amplifications were carried out in 50 μL with 10 mM Tris-HCl buffer (pH 8.3)
containing 10 mM KCl, 4.0 mM MgCl2, 250 μM dNTPs, 1 μM forward and reverse
primers (50 pmol of each primer), and between 1 and 50 ng of genomic DNA extracted
from the cell lines as described above. The set of primers used were: Ex.1.3 forward =
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5’ AAC CTT ATG TGT GAC ATG TTC TAA TAT AGT CAC 3’; Ex.1.4 reverse = 5’ AAA
ATG GTC AGA GAA ACC TTT ATC TGT ATC 3’; Ex.2.9 forward = 5’ TCA GGA TTC
CTA CAG GAA GCA AGT AGT 3’ and Ex.2.11 reverse = 5’ ATA CAC AAA GAA AGC
CCT CCC CA 3’.

After a 1 min denaturation step, 1.5 units of Amplitaq DNA

polymerase (Perkin Elmer, Norwalk, CT) was added under hot start conditions and
amplification was achieved by thermally cycling for 35 - 40 cycles at 95ºC for 30 s; 60ºC
for 1 min; 72ºC for 1 min and 72ºC for 3 min for a final extension. PCR products were
stored at –20ºC until required for use.
3.2.8 LDR Reagents and Conditions
LDRs were carried out using conditions similar to those published elsewhere
[16]. Briefly, the PCR products were used as templates for the ligase reaction. The
appropriate ratio of wild-type to mutant sequence was added to a solution containing 1X
Tth ligase buffer (10 mM Tris-HCl (ph 7.6), 10 mM MgCl2, 0.1 M KCl and 20 μg/mL
bovine serum albumin), 10 mM DTT, 1.25 mM NAD+ (nicotinic adenine dinucleotide, a
cofactor for ligase enzyme) and 500 nM of each discriminating primer taken to a final
volume of 20 L. The mixture was heated to 94 C for 1.5 min prior to adding 1 nM Tth
DNA ligase (received from Cornell). LDRs were thermally cycled 20 times at 94 C for
15 s and 65 C for 4 min. Reactions required cleanup prior to CGE using a cold ethanol
precipitation to reduce the amount of salts. This was carried out by adding 7 µL of 7 M
NaOAc and 100 µL of 100% cold ethanol to the LDR. The solution was vortexed and
placed in a refrigerated centrifuge for 30 min at 10,000 rpm at 4 oC. The supernatant
was removed and the reactions thoroughly dried in a Centro-Vap (Brinkman
Instruments, Westbury, NY, USA) for 1 hr. The DNA pellet was then reconstituted in
ddH2O (10 µL) and vortexed for 1 min prior to CGE.
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3.3 Results and Discussion
3.3.1 LDR Modeling Samples Using CGE
Modeling samples were made using synthetically generated DNA fragments
labeled on their 5’ ends with fluorescein to mimic LDR- generated products in the
presence of excess LDR primers. The fluor-K-ras C12.2A (25 bp) oligonucleotide was
used at 10, 100 and 1,000 times molar excesses of the synthetic LDR products (44 and
51 bp oligonucleotides). Considering a sample of one mutated DNA for every 20 wildtype sequences and an LDR cocktail consisting of three discriminating primers (500
fmol each – 1,500 fmol total) and 20 thermocycles, the enzymatic reaction can
Table 3.2. Results from model studies of an LDR assay using 5T5C, eCap and POP5
matrices with CGE. Efficiency (plate numbers, N) was calculated for the 25 (unligated
primer model), and the 44 and 51 bp fragments (ligation product models). Resolution
was calculated between the 25 bp and 44 bp oligonucleotides as well as for the 44 and
51 bp LDR product models.

potentially yield 500 fmol of LDR product if 100% ligase efficiency is achieved using
optimal conditions.

Because 500 fmol of discriminating primer (one allele) are
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consumed in the reaction, this results in a 1:2 ratio of LDR product to discriminating
primer (500 fmol LDR product to 1,000 fmol discriminating primer).

In an 1:1,000

(mutant:wild-type) sample, LDR should produce ~1:150 molar excess of discriminating
primer. If the ligation efficiency per cycle is lower than 100%, the ratio of LDR product
to unligated primers is much lower than that calculated here.
Modeling samples were analyzed under optimized conditions for CGE using the
5T5C capillary, the POP5 separation matrix and the eCap matrix. Efficiencies (plate
numbers) were calculated for the 25 bp discriminating primer as well as the 44 and 51
bp synthetic LDR products.

Resolution was calculated between the discriminating

primer and the 44 bp product, as well as between the 44 and 51 bp products. These
results are summarized in Table 3.2.
3.3.1.1 5T5C Analysis Using Synthetic Models
Using the 5T5C capillary, injection times required to load sufficient amounts of
the 44 and 51 bp products were 20 s, 45 s and 75 s for the 1:10, 1:100 and 1:1,000
LDR product model to discriminating primer (25 bp) molar ratio, respectively. Baseline
separation of all fragments was achieved in less than 45 min as shown in Figure 3.3 for
the 1:100 modeling sample. In some cases, efficiencies were better than 1 x 10 6 m-1,
but in no case was it less than 1 x 10 5 m-1. Inspection of the results shown in Table 3.2
indicated that the plate numbers decreased for the 25 bp oligonucleotide with
decreasing amounts of the 44 and 51 bp ssDNAs due to the longer injection times used.
This resulted in reduced resolution between the 25mer and 44mer.

However, the

opposite trend was generally observed for the 44mer and 51mer, with higher plate
numbers observed as the molar ratio of 25mer to the 44/51-mers was increased.
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A difficulty encountered when using this gel was the rapid rate of column
degradation, which appeared to be a result of longer injection times required to load
sufficient amounts of the longer oligonucleotides of lower concentration for detection. In
addition, since the gel could not be removed from the capillary, the entire capillary
needed to be replaced following column failure.

Manufacturer supplied information

reported lifetimes greater than 20 hours. However, in our case, we found that we could
perform only 10 separations before the capillary displayed significant degradation in
performance (~10 h of operation).

Figure 3.3. Analysis of a 1:100 modeling sample using the 5T5C gel. The capillary
column was 36 cm in length (30 cm effective length) and it was maintained at 25ºC with
a run voltage of 9 kV and the sample was injected for 45 s at 10 kV.
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3.3.1.2 eCap Analysis
Analysis using the eCap gel column provided baseline resolution of all fragments
in less than 30 min. Similar trends in plate numbers and resolution were observed for
this gel matrix as that found with the 5T5C gel (see Table 3.2), with higher excesses of
the 25mer producing reductions in the resolution between the 25mer and 44mer as well
as smaller plate numbers for the 25mer. The model LDR products were well resolved in
the 1:10 and 1:100 samples (R = 4.56 and 7.40, respectively) and discrimination was
possible from the excess primer as shown in Figure 3.4 for the 1:100 sample.

Figure 3.4. Analysis of a 1:100 modeling sample using the eCAP gel. The neutrally
coated eCAP capillary was run at a voltage of 11.1 kV with the capillary maintained at
30 ºC. Electrokinetic injection was 20 s at 10 kV.
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Interestingly, we were unable to load sufficient amounts of the 44 or 51 bp
oligonucleotides when the 25mer was in 1,000-fold molar excess even when using
electrokinetic injection times up to 5 min. This may indicate that severe injection biases
occurred using this eCap matrix as compared to the 5T5C capillary.

As such,

analyzing samples with high molar ratios of short oligonucleotides cannot be
accomplished using this linear polyacrylamide gel.
3.3.1.3 POP5 Analysis
Analysis using the POP5 separation matrix was also able to separate
electrophoretically the LDR models and discriminating primer at the 1:10 and 1:100
molar ratios (see Figure 3.5 for the 1:100 sample). As can be seen from inspection of
Table 3.2, the POP5 gel generally provided less plates and poorer resolution for these
short ssDNAs compared to the eCAP and cross-linked gels. Severe loss in resolution
and efficiency resulted in subsequent injections if the matrix was not replaced after each
run. Injection times were 5 and 45 s for the 1:10 and 1:100 samples, respectively, while
injections of up to 5 min were unable to load sufficient amounts of the LDR models for
the 1:1,000 sample, similar to that observed for the eCAP gel.
3.3.2 CGE analysis of PCR/LDR Samples
Considering the severe injection biases encountered for injecting samples
electrokinetically with high molar excesses of unligated primers using the eCap and
POP5 separation matrices, LDR samples were analyzed using the 5T5C capillary, the
results of which are shown in Figure 3.6 (1:100 G12V mutant to wild-type) and Figure
3.7 (1:1,000 G12V mutant to wild-type). In all cases, the LDRs were cold ethanol
precipitated to remove excess salts prior to capillary injection to assist in loading the
ssDNAs. The injection time for the 1:100 sample was 40 s while the injection time was
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Figure 3.5. Analysis of a 1:100 modeling sample using the POP5 matrix. The capillary
column was 36 cm in length (30 cm effective length). The POP5 analysis of 1:100
modeling sample consisted of a bare silica capillary with a run voltage of 7.7 kV and
maintained at 50 ºC. The sample was injected for 45 s at 10 kV.
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Figure 3.6.
Analysis of a G12V 1:100 (mutant to wild-type) LDR sample.
Electrophoretic conditions were the same as those listed in Figure 3.3 for the 5T5C
column except that injection was for 40 s.

increased to 90 s for the 1:1,000 sample. With decreasing amounts of mutant template,
resolution between the LDR product and unligated primers decreased similar to our
model studies. The loss in resolution resulted from increased loading of the unligated
primers due to the longer injection times required and the biased injections favoring
loading of the shorter oligonucleotides. In both cases, the analysis required 36 min to
generate sufficient plates to resolve the LDR product from unligated primers. For the
1:100 mutant to wild-type sample, the resolution between the unligated primers and
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LDR product was calculated to be 3.14 and decreased to 1.51 in the 1:1,000 sample.

Figure 3.7.
Analysis of a G12V 1:1,000 (mutant to wild-type) LDR sample.
Electrophoretic conditions were similar to those for the 5T5C column in Figure 3.5
except injection was for 90 s.
3.3.2.1 Optimization of Electrophoretic Conditions Using Modeling Samples and
Microelectrophoresis
The matrices (linear entangled polymers and cross-linked gels) were problematic
for the detection of point mutations using LDR in the capillary format due to severe
injection biases, which required desalting of the LDR prior to gel loading.

These

injection biases were particularly problematic when the mutant strands were significantly
lower in abundance compared to the wild-types. Injection biases could potentially be
minimized in a microelectrophoretic format by incorporating cross “T” injectors that
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provide volume-based injections free from significant electrokinetic biasing effects. In
addition, the smaller formats associated with microchip electrophoresis could allow
higher sample throughput by reducing electrophoretic development time. Therefore, we
evaluated the feasibility of using a polymer-based microelectrophoresis chip for
analyzing LDR samples containing gene fragments of low abundance with point
mutations of clinical significance.
We investigated three different gel matrices for use with the PMMA microchip;
POP5, eCAP and a 4% linear polyacrylamide (LPA) containing 7 M urea as the
denaturant. In the case of the eCAP and LPA matrices, the PMMA microchip was used
without a coating to suppress its intrinsic electroosmotic flow, which has been measured
to be 1.4 x 10-4 cm2/Vs [22]. The POP5 gel contains a buffer, which suppresses the
EOF in conventional capillaries (fused silica), but the ability of this buffer to suppress the
EOF in polymer-based microchips has not been demonstrated. To test each matrix, an
equal molar solution of the 25 and 51 bp synthetic oligonucleotides were
electrophoresed in the microchip using an effective separation length of 3.5 cm.

In all

cases, the separations were performed at room temperature using an electric field
strength of 113 V/cm. The 4% LPA matrix provided the best resolution between these
synthetic oligonucleotides with R = 1.64, while the POP5 and eCAP matrices provided
resolutions of 1.20 and 1.19, respectively. In all three cases, baseline resolution was
achieved for these short single-stranded oligonucleotides, but the 4% LPA matrix
provided the highest resolution, which should make it appropriate for analyzing the
ligated products when the copy number of the mutants is significantly lower than the
wild-types. The plate numbers for these gels were comparable (~3.5 x 10 5 m-1)
indicating that the enhanced resolution observed for the 4% LPA matrix was due
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primarily to its higher selectivity for these short oligonucleotides. The injection conditions
used in these examples was 35 s using 500 V applied between the sample (A) and
waste (B) reservoirs (see Figure 3.2A).
For the eCAP and LPA matrices, the PMMA separations were performed in
uncoated microchannels producing acceptable results in terms of plate numbers and
migration times. Recently, it has been reported that successful DNA sequencing of
short tandem repeats (read lengths < 400 bp) can be obtained in polymer-based
microchips of 4.5 cm in length, but a coating procedure was required to secure
favorable results [23]. The coating procedure, which was used specifically to suppress
the

EOF

of

the

microchip,

consisted

of

2%

w/v

poly-

dimethylacrylamide/diethylacrylamide in water, with a 2 h incubation time. Our results
indicate that for the separation of short oligonucleotides as in the present case, no
coatings for EOF suppression are required for PMMA microchips. However, inclusion of
EOF suppression coatings may be necessary in these chips for longer oligonucleotides
due to their smaller apparent electrophoretic mobilities. In addition, the results obtained
by the eCAP and POP5 gel were similar in terms of their plate numbers and migration
times indicating that the POP5 gel and buffer system may not possess dynamic coating
capabilities in polymer microchips as they do for fused silica capillaries. This conclusion
is not too surprising given the differences in surface chemistries between these
materials.
Care was taken to optimize the injection conditions as well to prevent significant
band broadening resulting from sample leakage into the separation channel while at the
same time allowing complete filling of the fixed volume injector of the shorter
oligonucleotide (ie, LDR product). It was found that injections less than 15 s (using a
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500 V injection voltage) were insufficient for entirely filling the injection cross with the
sample while injections longer than 25 s resulted in excessive band broadening as
noticed by reductions in plate numbers. Using optimized injection conditions (t inj = 20 s;
V = 500 V) and an effective separation length of only 3.5 cm provided sufficient plate
numbers (N = 1.51 x 106 and 1.67x 106, for the 25 and 51 bp oligonucleotides,
respectively) to adequately resolve the generated LDR product from unligated primers
even when the mutant allele was in low copy number compared to the wild-type.
3.3.3 Microchip Electrophoresis of LDR Samples
In Figure 3.8 (A) and (B) are shown the microelectrophoretic results of an LDR
reaction containing the G12D mutant sequence only (A) and the wild-type only (B).
Also, a 1:100 molar ratio of mutant to wild-type alleles are shown in Figure 3.9. In all
cases, the LDR reaction was loaded directly into the appropriate reservoir of the chip
without subjection it to a desalting procedure. As can be seen, in the case of the wildtype only one peak appears in the electropherogram most likely arising from unligated
primers. In the case of the mutant allele, a new band appears at longer migration times
compared to the primer peak, resulting from a successful ligation of the common and
discriminating primers producing a 44 bp product in this case.
In Figure 3.9 is shown the results of a ligation assay where the wild-type allele was 100fold higher in concentration compared to the mutant allele. Using these electrophoretic
conditions, the LDR product could be resolved from unligated primers in under 120 s
with a resolution of 1.3, approximately 17-times faster than that observed using CGE
(see Figure 3.6) with only a slight reduction in resolution.
Microchip separations of two LDR mutations (G12D and G13D) generated in a
single reaction at low abundance levels of 1:10 and 1:100 mutant to wild-type ratios
[84]

Figure 3.8. Microelectrophoresis analysis of the G12D LDR product. (A) G12D mutant
LDR sample with no wild-type sequences, (B) the wild-type control sample (no mutant
sequences). The electrophoresis was run using a 4% LPA sieving matrix with 7 M urea
as the denaturant. The matrix was conditioned by pre-electrophoresis at 1 kV for 5 min.
The sample was injected for 20 s at 500 V and electrophoresed at 113 V/cm using
pullback voltages on the waste and sample reservoirs of 210 and 350 V, respectively.
The effective channel length was 3.5 cm (total length 10 cm).
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Figure 3.9. Microelectrophoresis analysis of a 1:100 mutant (G12D) to wild-type ratio.
The electrophoresis was run using a 4% LPA sieving matrix with 7 M urea as the
denaturant. The matrix was conditioned by pre-electrophoresis at 1 kV for 5 min. The
sample was injected for 20 s at 500 V and electrophoresed at 113 V/cm using pullback
voltages on the waste and sample reservoirs of 210 and 350 V, respectively. The
effective channel length was 3.5 cm (total length 10 cm).

were later conducted with a custom, moderately viscous polymer solution composed
sparsely cross-linked ultra-high molar mass polyacrylamide “nanogel” [24].

The

polymer was reconstituted in 1xTTE buffer containing 7 M urea to a 2.75% (w/v)
concentration. As seen in Figure 3.10, using a field strength of 125 V/cm and the same
detection length of 3.5 cm, both LDR products for the 1:10 abundance ratio could be
resolved within ~4.5 min. Similarly the PMMA microchip separation of the 1:100 ratio
LDR sample, which is within range of biologically relevant levels, was successful.
[86]
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Figure 3.10. PMMA microchip separation using a 2.75% (w/v) nanogel for the sorting
of multiplexed LDR of G12D and G13D products at an abundance ratio of 1:10 (mutant
to wild-type) sample. The polymer was reconstituted in 1xTTE buffer containing 7 M
urea. The separation was conducted at 125 V/cm after a 35 s injection at 350 V/cm with
a detection length of 3.5 cm.

As seen in Figure 3.11, using the same parameters as listed for the microchip
separation of the 1:10 LDR sample in Figure 3.7, both products were present after ~4.5
min of development time.
3.4 Conclusions
Several ssDNA separation matrices for CGE were evaluated for their ability to detect
low abundant point mutations using LDR. The eCap and POP5 replaceable matrices
provided successful separation of model LDR products at 1:10 and 1:100 molar ratios to
the synthetic unligated model primers with sufficient resolution in less than 35 min, but
with lower resolution compared to the 5T5C cross-linked gels. The eCap matrix
[87]
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Figure 3.11. PMMA microchip separation using a 2.75% (w/v) nanogel for the sorting
of a multiplexed LDR of G12D and G13D products at an abundance ratio of 1:100
(mutant to wild-type). Run conditions were the same as those listed in Figure 3.7.

required a neutrally coated capillary to suppress the EOF or prevent solute-wall
interactions, which would adversely affect electrophoretic efficiency.

The POP5 gel

provided dynamic coating capabilities of the capillary that permitted use of a bare fused
silica capillary with no pretreatment necessary.

While these gels provided baseline

resolution for these model LDR samples of relatively low molar excess of unligated
model primers, they suffered from severe injection biases and appeared inadequate for
the detection of samples containing an 1,000-fold molar excess of unligated primer.
Under the conditions listed here, sufficient loading of the LDR products was not
possible.
[88]

The 5T5C cross-linked capillary provided analysis of molar ratios up to 1:1,000 of
LDR product to unligated primers with better resolution and efficiency as compared to
the eCap and POP5 matrices; however, increased column deterioration resulted from
unusually long injections required to sufficiently load LDR products.

The covalent

bonding of the polyacrylamide to the capillary wall prevented matrix replacement.
Microchip electrophoresis using uncoated polymer substrates demonstrated
potential for providing rapid analyses of LDR products. The volume-based injection
associated with these formats have been shown to provide representative loading of
various sized DNA fragments where electrokinetic injection in capillaries are subject to
biases favoring high mobility fragments and salts [21]. Initial microdevice separations
using a 4% LPA separation matrix were favorable in providing high efficiency
separations with adequate resolution in the size range of interest in as little as 120 s,
nearly 17-times faster than capillary gel formats. In addition, sample processing prior to
the electrophoresis was simplified by eliminating the need of desalting using ethanol
precipitation or other similar techniques.
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Chapter 4: Ligase Detection Reaction Mutation Screening via Free Solution
Electrophoresis in a Polymeric Microfluidic Device*
4.1 Introduction
The stochastic nature of molecular alterations during tumorigenesis makes
cancer diagnosis and prognosis using molecular profiling an arduous task. Cancers
often possess multiple mutations embedded within several different genes with varying
frequencies; in most cases, these mutations must be thoroughly probed to accurately
identify the presence or risk of developing a particular phenotype. For example, 3050% of all colorectal adenomas are marked by the presence of one or more of the 19
known mutations found in the K-ras oncogene alone [1-4]. Most K-ras mutations are
localized to codon 12 and to a lesser extent, codons 13 and 61; these mutations are
well preserved throughout tumor progression. Testing for these mutations is difficult
because the percentage of cells with mutated DNA fluctuates greatly with respect to the
stage of tumorigenesis and the location and proximity of the sampling site with respect
to the primary tumor site [5-10]. For example, colorectal cancer (CRC) sampling of
plasma samples from CRC patients found only 0.01% to 1.7% of the 47,800 APC
molecules collected per mL of plasma contained mutant alleles [11].
primary tumor site, the predominant cells are normal

Even at the

stromal cells (wild-type; WT)

found at levels as high as 70% [12]. Successful and accurate genotyping for CRC
therefore not only depends on the utilization of a multiplexed analysis format, but also
the ability to detect low copy numbers of mutated sequences in a vast sea of WT DNA.
One technique that can distinguish low abundant mutant DNA from WT DNA in a
multiplexed format is the ligase detection reaction (LDR) coupled to a primary PCR [1320].

Following PCR amplification of the appropriate genes containing the loci of

*Reprinted with permission from Electrophoresis.
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interest, the amplicon is mixed with two complementary primers (a common primer and
discriminating primer) that flank the mutation locus of interest. Conventionally, the
discriminating primer contains a base at its 3’ end that coincides with the single-base
mutation site. Facilitated by a highly specific thermally stable ligase, the two primers
are covalently joined to form an LDR product if and only if the nucleotide at the potential
mutation site is complementary to the 3’ end of the discriminating primer. This process
then linearly amplifies LDR products during subsequent thermal cycles; the products
that correspond to the presence of a mutation are approximately twice as long as the
original LDR primers. The flexible design of this primer ligation-based scheme has
allowed

successful LDR implementation onto

DNA

microarrays

as

well

as

electrophoretic sorting platforms [12, 13, 21].
Typically, stringent measures have been required to sort products generated
from LDRs, including cross-linked slab gels or capillary gel electrophoresis (CGE),
which typically require >1 h to achieve separations with adequate resolution [13].
Recently, microchip electrophoresis has successfully been used to score the presence
of mutations using LDR [22]. The use of microchips as a miniaturized electrophoretic
platform allows reduced analysis times and provides a platform for integration of frontend molecular processing to realize an autonomous lab-on-a-chip system, which can
reduce the potential for sample contamination and expand the user base of genetic
molecular analyses due to the automated nature of sample processing.

Using

inexpensive polymeric substrates for the fabrication of the fluidic elements will
dramatically reduce the overall cost of the analysis and make these platforms viable for
one-time use diagnostic applications [21, 23-27].
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An obstacle for the translation of capillary-based electrophoretic technologies to
microchips is the highly viscous sieving gels required for size-dependent separation of
DNA.

Viscous media lengthen the preparation and separation times and limit the

electric field strength that can be used and also demand robust devices to fill the
channels.

Gel loading devices and port assemblies constructed to address these

issues have had moderate success, but the relatively low pressures that microchips and
assembly interconnects can sustain make these solutions tenuous [28]. Furthermore,
maintaining the integrity of the assembled microchip becomes more difficult as pressure
drops increase due to increases in channel length for improvements in separation
resolution and multi-channel designs for high-throughput applications [29]. The use of
polymer-based electrophoresis exacerbates this problem due to their inability to
withstand high gel loading pressures.

Moreover, the chemical composition and/or

concentration of the sieving matrix must often be modified to accommodate only a
limited size range of DNAs to be sorted [30].
In efforts to circumvent the necessity of sieving matrices for DNA separations,
end-labeled free solution electrophoresis (ELFSE), also referred to as free solution
conjugate electrophoresis (FSCE), was theorized and later demonstrated [31-33].
FSCE is an attractive separation technique for sorting charged biopolymers without the
need of a sieving medium.

In FSCE, a monodisperse, uncharged polypeptide or

polypeptoid “drag-tag” is conjugated to DNA to disrupt the free-draining behavior of
DNA in an electric field [33].

In this regime, the size of the DNA determines its

electrophoretic driving force, which is countered by the frictional and hydrodynamic drag
from the appended drag-tag.

The conjugates of DNA and drag-tags can then be

[93]

separated by size using electrophoresis in free-solution (with no polymer matrix
present); the molecular weight and other properties of the drag-tag determine the length
of DNA that can be separated with single-base resolution by FSCE possible. With the
size range of monodisperse drag-tags now available, DNA separations of ~180 bases
have been demonstrated and this electrophoretic approach has proven useful for
sequencing and also single base extension (SBE) genotyping with free solution
separations performed in both capillaries and glass microchips [34-36].
Here, we present the combination of LDR and FSCE (LDR-FSCE) to create a
novel, multiplexed electrophoretic method to screen low-copy number mutations (in a
high abundance of WT DNA) using
without a sieving matrix.

poly(methyl methacrylate), PMMA, microchips

Because the desired fragment lengths of LDR products in

addition to their fluorescent probes are relatively small and require single base
separation performance (42 – 46 bp), a combination of viscous matrices and relatively
long column lengths are usually needed to sort them. In our previous work involving
PMMA microchip separations of LDR products, a few commercially available polymer
matrices optimized for capillaries and glass microchips were investigated [22]. Although
effective, none exhibited the degree of performance required to separate multiple LDR
products in this particular size range. In LDR-FSCE, LDR primers were conjugated to
polypeptoid drag-tags to efficiently resolve fluorescently-labeled LDR products
generated from K-ras mutations with a high diagnostic value for CRC [37, 38]. Using
this FSCE approach, rapid separations (~85 s) of LDR/drag-tag conjugates (LDR-dt)
were achieved in PMMA microchips using only a Tris-based buffer containing an
electroosmotic flow (EOF) suppression additive.
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4.2 Methods and Materials
4.2.1 DNA Template Preparation
Genomic DNA was extracted from cell lines of known K-ras oncogenic
expression associated with the onset of CRC (HT-29, wild-type; SW1116, G12A;
SW620, G12V; LS180, G12D; and DLD1, G13D) (ATCC, Manassas, VA) using a
Qiagen DNeasy kit (Valencia, CA). Here, the nomenclature of the given mutations (i.e.,
G12D) denotes the DNA base substitution (G) within a particular codon (12; GGT) in
exon 1 of the K-ras gene, which alters the amino acid translation from glycine to
aspartic acid (D). PCR amplifications were carried out to generate 290 bp amplicons of
each template in 50 μL volumes containing 10 mM Tris-HCl buffer (pH 8.3, 10 mM KCl,
4.0 mM MgCl2), 250 μM dNTPs, 1 μM forward and reverse primers (50 pmol of each
primer), and between 1 and 50 ng of genomic DNA extracted from the cell lines. The
gene-specific primer sequences were; exon 1.3 forward - 5’ AAC CTT ATG TGT GAC
ATG TTC TAA TAT AGT CAC 3’ and exon 1.4 reverse - 5’ AAA ATG GTC AGA GAA
ACC TTT ATC TGT ATC 3’. After a 2 min initial denaturation, 1.5 units of AmpliTaq
DNA polymerase (Applied Biosystems, Foster City, CA) was added under hot-start
conditions and amplification was achieved by thermally cycling for 35 cycles at 95ºC for
30 s, 60ºC for 1 min, 72ºC for 1 min with a final extension at 72ºC for 3 min.
4.2.2 Drag-tag Synthesis and Primer Conjugation
The synthesis of the four, linear poly N-methoxyethylglycine (NMEG) drag-tags
(length = 20, 32, 44 and 56 monomers) utilized in this study (see Figure 4.1) was
achieved using a solid-phase submonomer synthetic protocol, which has previously
been described in detail and was accomplished using an ABI 433A automated peptide
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synthesizer [39, 40].

All drag-tags were capped with an N-terminal maleimide and

purified to monodispersity by RP-HPLC. The discriminating primers used for the LDRs
were purchased from IDT (Coralville, IA) and contained a C-6 spacer and thiol linker
modifications on their 5’ terminus to facilitate the attachment of the drag-tags (see Table
4.1). Common primers were synthesized bearing either FAM (excitation/emission =
492/517 nm; IDT) or IRD-800 (excitation/emission = 780/816 nm; LI-COR, Lincoln, NE)
fluorescent labels (z) on their 3’ ends with phosphorylation on their 5’ termini (see Table
4.1). The thiol groups on the discriminating primers were reduced by incubating the
primers with a 20x molar excess of TCEP, tris(2-carboxyethylphospine; Acros Organics,
Morris Plains, NJ) in pH 7.2 100 mM sodium phosphate buffer at 40ºC for 90 min. The
drag-tags were conjugated to the 5’ termini of the discriminating primers using a 1:20:28
primer:TCEP:drag-tag concentration ratio in pH 7.2 100 mM sodium phosphate buffer
that was incubated at room temperature for 3 h [35]. The largest polypeptoid drag-tags
(56 monomers) were paired with the corresponding smallest discriminating primers
(21bp), and vice versa, to generate the greatest possible resolution between the LDR
products (see Table 4.1) [35].
4.2.3 LDR of Drag-tag/DNA Primer Conjugates
LDR assays were carried out using conditions similar to those described
elsewhere with slight modifications [22].

Briefly, appropriate ratios of the

aforementioned WT and mutant amplicons were added to a solution containing 1x Taq
DNA Ligase buffer (20 mM Tris-HCl, 25 mM potassium acetate, 10 mM magnesium
acetate, 10 mM dithiothreitol, 1.0 mM NAD) at pH 7.6 (New England Biolabs, Beverly,
MA) and 25 nM of each discriminating and common primers taken to a final volume of
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20 L with ddH2O. After an initial 2 min denaturation at 94ºC, 40 U of Taq DNA ligase
(New England Biolabs) was added to the cocktail under hot-start conditions and the
reactions were thermally cycled 20 times for 15 s at 94ºC and 2 min at 65ºC. The
reaction was then quenched by rapid cooling to 4ºC followed by the addition of 0.5 mM
EDTA. Prior to electrophoretic analyses, samples were desalted using CentriSep spin
columns (Princeton Separation, Adelphia, NJ).

Table 4.1. Design of Primers for LDR-ELFSE.

4.2.4 Microchip Fabrication
Microchips were fabricated using methods previously developed and reported by
our group [41].

Briefly, the procedure involved machining a molding die by milling

raised microstructures onto a brass plate. These microstructures formed a separation
channel with dimensions of 70 m (depth) x 30 m (width) and 9.5 cm in length (total)
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with 0.5 cm intersecting side channels offset by 500 µm, which provided a defined 105
pL volume for sample injection. These microstructures were embossed into PMMA
wafers (MSC, Melville, NY) using an embossing system consisting of a PHI Precision
Press model number TS-21-H-C (4A)-5 (City of Industry, CA) and a vacuum chamber
connected to the press to remove air (pressure < 0.1 bar). The microchannel pattern
was transferred into a PMMA wafer at 155°C and 1000 lb for 4 min.

After hot-

embossing, the press was opened and the polymer wafer was cooled to room
temperature.

Reservoirs were added to the microchips by drilling 1.25 mm holes

centered at the end of each channel. After an ethanol rinse and sonication in ddH 2O for
debris removal, the final device was assembled by annealing a PMMA cover plate to the
open face of the device by clamping between glass plates (~10 lb) and heating to 107 C
in a circulating air oven for 20 min.
4.2.5 Laser-induced Fluorescence (LIF) and High Voltage Control System
A laser-induced fluorescence (LIF) detection system was constructed in-house
with an epi-illumination configuration. A diode 780 nm laser filtered with a band-limiting
line filter (Thorlabs, Newton, NJ) was directed onto a dichroic mirror, which reflected the
excitation beam through a 40x microscope objective (Newport, Fountain Valley, CA) into
the microchannel, which was situated on an X-Y-Z micro-translational stage.

The

fluorescence emission was filtered through a filter stack and focused onto a single
photon avalanche diode (model SPCM-AQR-12, Optoelectronics, Vaudreuil, Canada).
The filter stack consisted of an 825 nm bandpass filter (Oriel, Stratford, CT) and an 800
nm long-pass filter (Edmund Scientific, Barrington, NJ). The LIF signals were acquired
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on a personal computer using a 32-bit counter/timer board (Model PCI-6601, National
Instruments, Austin, TX).
A custom Labview program was used to control applied voltages for the
microchip electrophoresis. The unit included three internal high voltage power supplies
(EMCO, Sutter Creek, CA) capable of receiving inputs of 0 or +5 V from a DAC (digitalto-analog converter) output of a CYDDA 04P board (CyberResearch, New Haven, CT).
These power supplies were capable of delivering 0 to +2 kV to sample and waste
reservoirs (EMCO Model C20, Sutter Creek, CA) and +0.3 to +5 kV to the anodic
reservoir (EMCO Model G50), all of which could be dynamically altered throughout the
separation.
4.2.6 Capillary and Microchip LDR-FSCE Conditions
Separations of the LDR products were performed on an ABI 3100 (Applied
Biosystems) using 36 cm (47 cm total separation length) capillaries filled with 1x TTE
(89 mM Tris, 89 mM TAPS, 2 mM EDTA) and 7M urea buffer containing 0.5% (v/v)
POP6 (Applied Biosystems) to dynamically coat the capillary walls to suppress the EOF.
Samples were electrokinetically loaded into the capillaries by applying 43 V/cm for 20 s
and electrophoresed at 320 V/cm.

For the microchip analysis, separations were

performed at room temperature using microchannels filled with 1x TTE (50 mM Tris, 50
mM TAPS, 2 mM EDTA) and 7M urea buffer containing 0.05% (w/v) methyl
hydroxyethyl cellulose, MHEC, (Sigma Aldrich, St. Louis, Mo) to dynamically coat the
PMMA channel walls for EOF suppression [42]. To generate a volume-defined injection
plug, 347 V/cm was applied for 50 s from the sample reservoir (ground) to the waste
reservoir (+ 3.5 kV). Electrophoresing of the sample was conducted using 365 V/cm,
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while adduction field strengths of 345 and 276 V/cm were applied to sample and waste
reservoirs, respectively, to prevent extraneous sample leakage into the separation
channel.
4.3 Results and Discussion
4.3.1 LDR-FSCE Genotyping
In order to conduct FSCE separations of LDR products, LDR primers were
reconfigured to allow for the addition of drag-tags onto the 5’ terminus of the
discriminating primers. LDR primers intended for electrophoretic separation in a sieving
medium are typically designed with discriminating primers bearing fluorescent labels on
their 5’ termini [18]. In this case, LDR primer sets were modified in a similar manner to
those previously used for microarray studies [12]. As illustrated in Figure 4.1 and Table
4.1, the fluorescent label was placed on the 3’ terminus of the common primer, which
also contained a 5’ phosphorylation modification to facilitate covalent coupling of the two
primers in the event of a successful ligation event due to primer complementarity with
the mutant allele. A thiol group was positioned on the 5’ terminus of the discriminating
primers, which served as the reactive site for drag-tag attachment.
LDR assays were initially performed using thermocycling conditions and primer
concentrations previously optimized for conventional primer-based procedures to
establish LDR parameters suitable for drag-tagged primers.

To verify successful

conjugation of the drag-tag with the thiolated oligonucleotides as well as the ability to
generate LDR products without interferences stemming from drag-tag presence, single
primer set positive control reactions (4) were conducted consisting of one drag-tagged
modified discriminating primer (G12D-dt, G12A-dt, G12V-dt, and G13D-dt, see Table
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4.1) and its respective dye-labeled common primers with individual K-ras mutant
templates. In addition, the same reactions were performed with discriminating primers
with no drag-tags using the G12D mutant template for comparison.

Figure 4.1. Diagram showing the generation of drag-tagged LDR products and their
subsequent separation profile from a mixed population of these LDR-dt products. LDR
primers having single base differences upon successful ligation are inversely paired
with drag-tags of different sizes (largest drag-tag to smallest ligated-primer pair). Under
an electric field, each LDR-dt conjugate has a unique electrophoretic mobility in free
solution whereas the non-conjugated primers have a mobility that is independent of
size. Larger LDR-dt products having greater overall charges migrate faster than LDR
products comprised of smaller oligonucleotides.
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4.3.2 CE Analysis of the LDR-dt Products
FSCE separations of the LDR-dt control samples were conducted using an ABI
3100 system for optimizing the LDR-dt reaction parameters. Figure 4.2 shows the
successful generation of LDR-dt products for all four K-ras mutant templates. As can be
seen, all LDR-dt products were effectively resolved from excess dye-labeled common
primers, which tended to mask LDR products due to their much higher concentration.
The FSCE separation required ~11 min.

Each product possessed a unique

electrophoretic mobility yielding resolutions between the dye-labeled common primer
and LDR-dt products of 4.33, 6.54, 8.50, and 12.27 for the G12V-dt, G12A-dt, G12D-dt
and G13D-dt products, respectively. As expected, the relative migration times of the
LDR-dt conjugates corresponded to the size of the drag-tag units appended to the given
LDR-dt products in that the LDR-dt product with the largest drag-tag eluted last and that
with the smallest drag-tag eluted first (See Table 4.1).
In a direct comparison, the separation of the non-drag-tagged G12D LDR sample
is shown in Figure 4.2. In this case, no LDR product was visible after the separation as
the LDR product co-migrated with the unincorporated labeled common primers in free
solution, thus illustrating the pronounced effects of drag-tags on the mobility of the LDR
products. However, the presence of a G12D LDR product was illustrated upon the
separation of the sample using gel electrophoresis (data not shown), but required a
development time of ~36 min with a resolution of 3.14 [22].
It was discovered that extending the denaturation time during the LDR cycling
beyond 2 min at 95ºC lead to partial hydrolysis of the maleimide linker between the
primers and the drag-tags, which caused the formation of minor LDR product peaks with
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Figure 4.2. Free solution CAE electropherograms of positive control samples and
multiplex LDR-dt samples that are probing four K-ras mutations. Four positive control
LDR assays consisting of each mutagenic template paired with its respective
discriminating (drag-tagged) and common primer. A negative control LDR assay
excluding drag-tags was conducted and analyzed via FSCE for comparison. The
reactions consisted of 1 nM of each mutagenic template with 25 nM each of the
common and discriminating primers per reaction in 1x Taq ligase buffer and 40 U Taq
ligase (20 µL total reaction volume). Thermocycling conditions included 20 cycles of
95°C for 20 s and 65°C for 2 min following a 2 min initial denaturation at 95°C.
Electrokinetic injections and separations were performed in 1x TTE buffer containing 7
M urea and 0.5% POP6 (for EOF suppression) at E = 416 V/cm for 10 s for injection
and E = 375 V/cm for the separation.

slight mobility shifts. During initial experiments, the relative peak areas indicated that
LDR products generated for G12D and G13D mutations, which are the most commonly
found K-ras mutant alleles, were approximately 20-fold greater than LDR products
[103]

generated for the less frequently occurring G12A and G12V mutations [43]. To increase
their visibility in the electropherograms in subsequent results, the relative amount of
G12A and G12V LDR-dt products were enhanced by increasing their genomic template
concentrations from 50 pmol to 100 pmol prior to PCR amplification.

Additionally,

subsequent reactions were performed by adding the drag-tagged discriminating primers
after the initial denaturation step used in the LDR phases of the assay to minimize
primer-dt degradation. Also, it was determined that the incorporation of drag-tags did
not appreciably affect the melting temperature of the LDR primers by comparing product
yields from experiments performed at different annealing temperatures (data not
shown).
Once optimal conditions were established for the LDR-dt assays, a single-tube
multiplexed reaction was conducted using FSCE for sorting the LDR-dt products. The
reactions consisted of concurrent generation of all K-ras amplicons (multiplexed PCR)
from which a measured aliquot was then LDR cycled with a mixture containing all four
drag-tagged discriminating primers (100 nM each) and two common primers (50 nM
each) to demonstrate the ability of this mutation detection scheme to probe mutations
within the same locus or having close proximity with high fidelity. The electropherogram
depicted in Figure 4.3 shows the separation of the simultaneously generated LDR-dt
products whose unique migration times approximately matched those established in the
initial control experiments.

Likewise, the relative peak areas for G12D and G13D

mutant alleles were approximately 10-fold greater than the G12A and G12V mutant
allele signals consistent with the relative abundance of these mutations.
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Figure 4.3. Free solution CAE electropherograms of positive control samples and
multiplex LDR-dt samples that are probing four K-ras mutations. A FSCE separation of
four K-ras LDR-dt products generated simultaneously in a single-tube reaction using the
entire panel of mutant templates and LDR primers (see Table 4.1 for sequences). The
reaction and run conditions were the same as listed in Figure 4.2.

4.3.3 PMMA Microchip LDR-dt Separations
PMMA microchip FSCE separations of positive control samples were performed
using the described in-house constructed LIF and high voltage control system. Two
important factors that must be considered when using polymer microfluidic devices as
electrophoretic platforms for genotyping are the pressure tolerance of the device and
the ability to manage the EOF of the polymer substrate surface, which sometimes varies
from batch-to-batch in different feedstocks of PMMA.

Here, both issues were

addressed through the use of free solution electrophoresis, which eliminated the need
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for pressurized introduction of highly viscous sieving media into the microchannels of
the devices and a dynamic EOF suppression coating, which required the inclusion of
0.05% MHEC (w/v) in the running buffer, well below its entanglement threshold [42].
EOF measurements for the PMMA microchip showed that the running buffer containing
MHEC attenuated the EOF to 1.49 ± 0.07 x 10-5 cm2/V s, which was consistent across a
number of different PMMA chips and one order of magnitude lower than that obtained
for untreated PMMA microchips (1.77 ± 0.11 x 10-4 cm2/V s).
Figure 4.4 illustrates the separation of K-ras LDR-dt products using a PMMA
microchip. Similar to the capillary separations, the results for each mutant allele were
baseline resolved from the free dye-labeled primers. The separations using the PMMA
microchips were completed in ≤ 85 s with an effective separation length of 3.5 cm and a
field strength of 365 V/cm, which provided resolution values of 2.13, 2.32, 2.77, and
3.25 between the dye-labeled common primer and LDR-dt products G12V-dt, G12A-dt,
G12D-dt and G13D-dt, respectively. As many as five consecutive separations could be
performed on the same microchip without requiring replenishment of the sample or
changing the buffer used for the electrophoresis. No carryover contamination from runto-run was observed when adduction voltage fields were applied to the sample reservoir
during injection.

Using these parameters, migration times were highly reproducible

(e.g., Tm= 81 s ± 1.8 s for G12D-dt) over five successive runs as well as for chip-to-chip
trial analyses.
Microchip FSCE separations of multiplexed LDR-dt samples were also
conducted for the simultaneous detection of all four mutant alleles. The experiment was
carried out using the same conditions given in Figure 4.4, except the genomic G12A
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Figure 4.4. Microchip FSCE separations of positive control K-ras LDR-dt reactions.
The custom-micro-milled PMMA microchip was hot embossed from a brass master (9.5
cm length, 30 µm width and 70 µm depth) utilized to separate the LDR-dt products
generated using the same conditions given in Figure 4.2. The volume-defined cross
injection (105 pL) and separation were performed in 1x TTE containing 7 M urea and
0.05% MHEC (for EOF suppression) at E = 365 V/cm for 50 s (injection) and E = 375
V/cm for the electrophoretic separation. Typical analyses used an effective channel
separation length of 3.5 cm.
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Figure 4.5. Microchip FSCE separation of a multiplexed LDR generating LDR-dt
products. Following PCR of the mutagenic K-ras loci in a single-tube reaction, a
multiplexed single-tube LDR was conducted using the conditions stated in Figure 4.2
with an increase in genomic DNA for G12A and G12V templates to 100 pmol prior to
PCR. The effective channel separation length was 6 cm and E = 450 V/cm were
selected to optimize the resolution of all LDR-dt products. The other separation
conditions were indentical to those described in Figure 4.4.

and G12V template quantities were increased from 50 pmol to 100 pmol prior to PCR
amplification in order to provide peak intensities similar to the predominant G12D and
G13D alleles. As seen in Figure 4.5, all four LDR-dt products were separated within
~165 s using a field strength of 450 V/cm at an effective distance of 6.0 cm to provide
near baseline resolution of all products.

At this high field strength, no physical

alterations of the microchannels were observed under magnification as well as no
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deleterious effects on separation performance in terms of plate numbers due to Joule
heating.
In order to evaluate the ability to score the presence of these mutations when
present in low abundance compared to the WT alleles, LDR-dt assays were conducted
using G12D and G13D K-ras mutants at biologically relevant levels (1 mutant copy per
100 WT copies) by adding 5.0 nM WT template to 0.05 – 5.0 nM of mutant templates to
construct 1:1, 1:10 and 1:100 excesses of mutant-to-WT samples. LDR-dt products
were visible in the electropherograms for both K-ras mutant templates at levels up to
1:100 at a SNR = 7.1 (see Figure 4.6). Attempts to detect LDR-dt products lower than
1:100 were not successful due to the detection limit of the LIF system and
electrophoretic masking resulting from the high peak intensities of the unligated
fluorescently-labeled primers. A negative control reaction excluding the K-ras mutant
templates conducted for 5.0 nM WT DNA showed no visible peaks indicative of the
formation of misligated products. Thus, there is minimal probability that this LDR-FSCE
assay will give false positive results. The PCR/LDR technique is capable of maintaining
high specificity in low abundance conditions due to: i) the thermostable ligase, which
has the ability to rapidly dissociate from junction sites containing mismatches; and ii)
early misligation events are not further amplified [13]. For example, in the case of
amplification techniques based on allele-specific PCR, fluorescent mutant sequences
are directly produced, which can generate false positives from misincorporations of
nucleotide bases by the polymerase. Here, the PCR serves only to amplify target DNA
sequences and the presence of mutations within these DNA sequences are discerned
by a follow-up allele-specific ligation.
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Figure 4.6. Microchip FSCE separations of multiplexed K-ras LDR-dt reactions probing
the G12D and G13D mutant alleles with changes in the relative abundances of wild-type
alleles with respect to the mutant alleles. The reaction compositions consisted of 5.0
nM WT template to 0.05, 0.5 and 5.0 nM of the mutant templates to construct 1:1, 1:10
and 1:100 excesses of mutant-to-WT samples, respectively. Separations used the
same conditions as those given in Figure 4.4.

4.4 Conclusions
We have demonstrated the successful genotyping of four clinically relevant K-ras
markers important for diagnosing CRCs by a hybrid LDR-FSCE method that generated
fluorescently labeled LDR-dt products. The versatility of the LDR-FSCE method allows
for multiplexed, highly specific mutation profiling of samples containing up to 100-fold
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excess of WT sequences on a plastic microchip. The LDR-dt products were separated
in 11 min on a commercial CAE system and ~85 seconds on a dynamically coated
separation channel of a PMMA microchip that was replicated via hot-embossing. LDRFSCE is a highly flexible method; drag-tags are ideal for genotyping applications that
require high-resolution separations of short oligonucleotides. Moreover, the absence of
a highly viscous sieving matrix also simplified the operation of the chip-based
electrophoresis by eliminating the need for gel filling prior to the electrophoretic
analysis. Thus, narrower channel dimensions to improve electrophoretic efficiency or
increasing the channel number within the device to improve throughput could be
realized without the constraints of high pressure that can result in device failure due to
disassembly.
Future work will include the integration of genomic sample pre-processing,
including DNA extraction and thermal cycling, onto a polymeric wafer to produce
autonomous systems appropriate for genotyping applications that do not require sieving
matrices or gel-filling apparati [44]. In additions, improvements in FSCE performance to
handle highly multiplexed assays can be realized with the utilization of polyamide dragtags of larger sizes. The degree of multiplexing will also be increased to probe the
entire panel of 19 K-ras mutations associated with the development of CRC as well as
other well characterized disease states by the incorporation of a larger array of dragtags.
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Chapter 5: Evaluating Low Frequency p53 Mutations Using an Endo V Mutation
Scanning Assay and Microchip Electrophoresis
5.1 Introduction
An accumulation of genetic mutations stemming either from inherited or somatic
alterations are ultimately responsible for spawning most cancer-related diseases.
Overall, approximately 90% of all cancers are attributed to somatic mutations, ~20% are
the result of germline mutations and ~10% involve both types [1]. The Human Genome
Project (HGP) has resulted in a rapid progression of the identification and
characterization of many deleterious genetic alterations that can be associated with a
variety of diseases, including cancer [2]. This information has provided insights into the
structure and function of oncogenes and tumor suppressor (TS) genes both of which
play a pivotal role in tumorigenesis.

Oncogenes produce growth and signal

transduction factors that promote cell growth and proliferation [3]. Meanwhile, active TS
genes, which are often found deactivated in my cancer-related diseases, regulate cell
growth and initiate apoptosis in cells that cannot be repaired, but under certain
circumstances, deactivated TS genes can be reactivated [4, 5].
The multiple and overlapping frequencies of many mutations associated with
particular cancers must be accurately mapped and evaluated in clinical settings to
realize diagnostic and prognostic metrics using these biomarkers. For example, K-ras
mutations in codons 12 and 13 occur in 80 – 90% of pancreatic cancer and 35 –50% of
colorectal cancers [6-8]; single nucleotide polymorphisms in BRCA1 and BRCA2
present at low frequencies (1 – 5%) are linked to significantly higher risks of developing
breast, ovarian or prostate cancers for certain ethnic groups [9].

A locus in

chromosome region 15q25 encompassing several genes - including three that encode
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nicotinic acetylcholine receptor subunits (CHRNA3, CHRNA4, and CHRNA5) – have
been found to account for 14% of 1,989 lung cancer cases, which were assessed in a
recent study [10]. The location of these mutations are well known and thus, can be
analyzed using mutation detection assays, such as allele specific ligation [11], allele
specific PCR [12] or allele-specific hybridization [13].
The presence or likelihood of developing cancer-related diseases have also been
related to the frequency or occurrences of sporadic p53 (TS gene) mutations [14]. The
challenge of evaluating these mutations is that they are often inundated by excess wildtype DNA in clinical samples at early stages of development and also, their locus is not
defined [15]. For instance, frequencies of sporadic p53 mutations in exons 5 – 9 can be
as low as one mutant per 1,000 wild-type (WT) sequences [16] and over 22,000 p53
mutations in different human cancers have been recorded and compiled in an
accessible database [17].
Several methods have been developed to detect sporadic mutations including
hybridization analysis using high-density oligonucleotide arrays [18], denaturing highperformance liquid chromatography (DHPLC) [19, 20], single strand conformational
polymorphism (SSCP) [21], denaturing gradient gel electrophoresis (DGGE) [22],
heteroduplex analysis (HA) [23] and dideoxy-sequencing [24]. Unfortunately, none of
these methods have the combined ability to provide low level detection when the
mutated DNA is in a large excess of WT DNA and also, pinpoint the exact location of
the sporadic mutations. Although dideoxy-sequencing can detect any single nucleotide
polymorphism and determine its location, the procedure is often time-consuming and
lacks the necessary sensitivity to detect low abundant mutant DNA in large excesses of
WT DNA.
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An approach for determining the approximate location of sporadic polymorphisms
even in the presence of large excesses of WT DNA is the use of enzymes, such as T4
Endonuclease VII to cleave mutational sites within double-stranded DNA [25, 26].
However, these methods generally suffer from miscleavages leading to false signals,
which limit their usefulness.
Recently, a one-step mutation scanning assay has been reported (see Figure
5.1), which employs Thermotoga maritima Endonuclease V (Endo V). Endo V is a
mutation nicking enzyme that clips a duplexed DNA molecule containing mismatched
base pairs (i.e., heteroduplexes). Unfortunately, Endo V can nick dsDNA at matched
sites as well that can be subsequently repaired using AK16D Taq ligase, which reduces
background signals from incorrect DNA cleavage events [27]. This particular Endo V
primarily recognizes and cleaves heteroduplexed DNA one base from the 3’-end with
respect to the mismatch. Combined with a ligase detection reaction (LDR) [28, 29] using
the Thermus species AK16D thermostable ligase, which displays up to a 5-fold better
discriminatory power compared to other ligases [30-32], this Endo V/LDR strategy has
been shown to provide sensitivity of up to 1:50 (Mutant to WT DNA) for the scanning of
sporadic p53 mutations.

Furthermore, this strategy employs universal PCR

amplification steps making it amenable to multiplexing [27]. The terminal step required
in this Endo V/LDR assay is a high-resolution electrophoresis step that sizes the DNAs
in their single-stranded form to determine the origin of the nicks induced by Endo V.
The technological trend towards miniaturizing electrophoretic platforms for DNA
separations initiated during the HGP has impacted genetic analyses for clinical
diagnostics/prognostics as well and has led to devices that provide high resolution
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separations that are potentially faster, possess simple operational characteristics and
have lower cost compared to conventional capillary electrophoresis.

Figure 5.1. Diagram illustrating the outcome of a successful Endo V/LDR treatment of
dye-labeled, heteroduplexed substrates. PCR amplicons of known wild-type cell lines
and mutagenic cell lines having high levels of sporadic mutations are cross-paired and
heteroduplexed to form Endo V targets. Endo V preferentially nicks DNA one base 3’ to
the mismatch, but also generates nonspecific nicks with minor activity. DNA ligase is
used either subsequently or concurrently with Endo V to reseal these background nicks.

In addition, these microchip electrophoresis devices can be integrated to upstream
sample pre-processing steps to create fully automated systems for mutation analysis.
Efforts have prompted the engineering of various high-throughput and highly integrated
electrophoretic devices in glass and, most recently, a host of polymeric substrates,
which are relatively inexpensive and conducive to a variety of high production-mode
fabrication techniques making them appropriate for clinical application, which require
one-time use devices to prevent false-positive signals arising from sample carryover
[33-36].
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Recently, mutation detection and scanning assays, which depend on an
electrophoresis step for reading the results of the molecular assay, have been
demonstrated. For example, mutation scanning assays that have been transitioned to
microchip platforms include SSCP and HA [37-39]. Many of these reports emphasized
numerous operational parameters, such as electrophoresis temperature and polymer
matrix/denaturing additive concentrations that must be optimized to provide highly
sensitive detection for mutational analyses possessing adequate resolution for detecting
the target mutations [40-42].
Here we present adaptation of the highly sensitive Endo V/LDR mutation
scanning assay onto a poly(methyl methacrylate), PMMA, microchip for separation of
the generated products using high-resolution electrophoresis for sorting the singlestranded products generated.

Comparisons of the separation performance for

identifying sporadic p53 mutations via Endo V/LDR performed using conventional
capillary gel electrophoresis and with polymer-based microchip gel electrophoresis will
be evaluated. The goal of this work is to assess the ability of this mutation scanning
assay to be transitioned to a microfluidic platform and its potential for detecting lowabundant sporadic mutations using microchip-based scanning methods.
5.2 Methods and Materials
5.2.1 Protocol for DNA Template Preparation
Genomic DNA was extracted from HT-29 and LoVo cell lines having known K-ras
oncogenic expressions associated with the onset of colorectal cancer (ATCC,
Manassas, VA) using a Qaigen DNeasy kit (Valencia, CA); the LoVo cell line contains
wild-type p53 gene mutations and HT-29 cell lines contain exon 8 R273H (G→A)
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mutations.

All

of

these

epithelial

cell

lines

were

obtained

from

colorectal

adenocarcinomas.
5.2.2 Protocol for Universal PCR Amplification
All primers used for Endo V/LDR were purchased from IDT (Coralville, IA) or
LiCOR Biotechnologies (Lincoln, NE). Universal PCR reactions for amplification of p53
exon 8 gene fragments followed by universal primer amplification (50 mL) containing 20
mM Tricine, pH 8.7, 16 mM (NH4)2SO4, 2.5 mM MgCl2, 0.2 mM of dNTPs, 0.2 mM of
each universal primer, 0.02 mM of each gene-specific primer, 5 U of AmpliTaq Gold
DNA polymerase and 150 ng of genomic DNA (see Table 1 for primer sets).

Table 5.1. PCR primers used for universal gene amplifications

The first thermocycling conditions in the bi-level amplification for the genespecific template amplification were: 95ºC for 10 min to activate AmpliTaq Gold
polymerase, followed by 20 cycles of 94ºC for 30 s, 65ºC for 1 min, 72ºC for 1 min.
Secondly, the universal amplification cycling conditions were: 30 cycles of 94ºC for 30 s,
55ºC for 1 min, 72ºC for 1 min, followed by a final extension step at 72ºC for 7 min. In
the universal PCR reaction, the universal primer pair consisted of a forward dye1labeled

primer

and

a

reverse

dye2-labeled
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primer

for

the

standard

denaturation/renaturation procedure. The dye1 and dye2 designation represent different
dye sets matching capillary array electrophoresis (CAE) and microchip detection
systems; for CAE analyses, dye1 and dye2 were FAM (ex./em.= 492, 517 nm) and HEX
(ex./em.= 538, 559 mn), while HEX and IRD-800 (ex./em.= 782, 812 nm) were used for
the microchip system. In this procedure, PCR amplification used one labeled universal
primer and one unlabeled universal primer (see Figure 5.2).
5.2.3 Preparation of Heteroduplexed DNA Substrates
For the denaturation/renaturation procedure required for heteroduplex formation
for the Endo V phases of the assay, approximately equal ratios of dye1/dye2-labeled
wild-type PCR amplicons were mixed with dye1/dye2-labeled mutant PCR amplicons in
a 12 mL final volume (1500 ng total DNA).

The wild-type control consisted of

dye1/dye2-labeled wild-type DNA PCR products alone in a 12 mL final volume (1500 ng
total DNA). The residual Taq DNA polymerase was inactivated by adding 1 mL of
proteinase K (20 mg/mL) to each mixture and incubating at 65ºC for 30 min, followed by
a 10 min incubation at 80ºC to deactivate the proteinase K. PCR mixtures were then
heated at 95ºC for 2 min, and gradually cooled to room temperature with a 0.2ºC
decrease in temperature every 15 s to 45ºC, and finally with a 10 min incubation at
25ºC to generate heteroduplexes as shown in Figure 5.2.
5.2.4 Endo V/ LDR Assay
A 6.5-µl volume of each denatured/renatured PCR mixture was incubated at
65˚C for 2 h in a 20 µl volume reaction containing a reaction cocktail (80 mM Tricine pH
8.0, 5 mM MgCl2, 5 mM dithiothreitol (DTT), 5% dimethyl sulfoxide (DMSO), 1.5 M
betain, 2% glycerol, with 500 nM Endo V, 6 nM Taq ligase (LDR repair enzyme) and 5
mM nicotinamide adenine dinucleotide (NAD), pH 8.5). Then, reactions were terminated
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with the addition of EDTA to a 10 mM final concentration to inhibit any further Endo V
cleavage activity. Using the given buffer conditions, both Endo V cleavage and LDR
DNA repair of miscleavages via thermostable ligation were carried out simultaneously.

Figure 5.2. Schematic illustration of the universal PCR amplification, labeling and
cross-pairing of wild-type LoVo and mutagenic HT-29 templates and the resulting
homoduplex (control) and heteroduplex targets.

5.2.5 Microchip Fabrication
Microchips were fabricated using methods previously developed and reported in
our group [33] . Briefly, the procedure involved machining a molding die by micro-milling
raised microstructures onto a brass plate. These microstructures formed a separation
channel with dimensions of 70 m (depth) x 30 m (width) that was 9.5 cm long with
0.5 cm intersecting side channels offset by 500 µm, which provided a defined 105 pL
volume for sample injection. These microstructures were embossed into PMMA plates
(MSC, Melville, NY) using an embossing system consisting of a PHI Precision Press
model number TS-21-H-C (4A)-5 (City of Industry, CA) and a vacuum chamber
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connected to the press to remove air (pressure, < 0.1 bar). The microchannel pattern
was transferred into a PMMA plate at 155°C and 1000 lb for 4 min.

After hot-

embossing, the press was opened and the polymer was cooled to room temperature.
Reservoirs were added to the microchips by drilling 1.25 mm holes centered at the end
of each channel. After an ethanol rinse and sonication in ddH2O for debris removal, the
final device was assembled by annealing a PMMA cover plate to the open face of the
device by clamping between glass plates and heating to 107 C in a circulating air oven
for 20 min.
5.2.6 Laser-induced Fluorescence (LIF) and High Voltage Control System
A laser-induced fluorescence (LIF) detection system was constructed in-house
with an epi-illumination configuration. A diode 780 nm laser filtered with a band-limiting
line filter (Thorlabs, Newton, NJ) was directed onto a dichroic mirror, which reflected the
excitation beam through a 40x microscope objective (Newport, Fountain Valley, CA) into
the microchannel, which was situated on an X-Y-Z micro-translational stage.

The

fluorescence emission was filtered through a filter stack and focused onto a single
photon avalanche diode (model SPCM-AQR-12, Optoelectronics, Vaudreuil, Canada).
The filter stack consisted of an 825 nm bandpass filter (Oriel, Stratford, CT) and an 800
nm long-pass filter (Edmund Scientific, Barrington, NJ). The LIF signals were acquired
on a personal computer using a 32-bit counter/timer board (Model PCI-6601, National
Instruments, Austin, TX).
A custom Lab-View program was used to control applied voltages for the
microchip electrophoresis. The unit included three internal high voltage power supplies
(EMCO, Sutter Creek, CA) capable of receiving inputs of 0 or +5 V from a DAC (digitalto-analog converter) outputs of a CYDDA 04P board (CyberResearch, New Haven, CT).
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These power supplies were capable of delivering 0 to +2 kV to sample and waste
reservoirs (EMCO Model C20, Sutter Creek, CA) and +0.3 to +5 kV to the anode
reservoir (EMCO Model G50), all of which could be dynamically altered throughout the
separation.
5.2.7 Capillary and Microchip Conditions for Endo V/LDR
Separations of the Endo V/LDR products were performed on an ABI 3730
(Applied Biosystems) using 36 cm (31 cm effective separation length) capillaries filled
with POP7 gel (Applied Biosystems), which was used in conjunction with POP7 buffer.
Samples were diluted 1 to 10 with HiDi formamide and 0.4

L of a Genescan size

standard (Applied Biosystems), which were denatured at 95ºC for 2 min (to ensure all
duplexes were converted to single strand form) and electrokinetically loaded into the
capillaries by applying 277 V/cm for 10 s and electrophoresed at 416 V/cm. For the
microchip

analysis,

separations

were

performed

at

room

temperature

using

microchannels filled with a 2.75% w/v sparsely cross-linked polyacrylamide suspended
in 1x TTE (50 mM Tris, 50 mM TAPS, 2 mM EDTA) buffer containing 7 M urea following
a rinse with 0.05% (w/v) methyl hydroxyethyl cellulose, MHEC (Sigma Aldrich, St. Louis,
Mo) to dynamically coat the PMMA channel walls for electroosmotic flow (EOF)
suppression [43]. To generate a volume-defined injection plug, 347 V/cm was applied
for 30 s from the sample reservoir (ground) to the waste reservoir (+ 3.5 kV).
Electrophoresing of the sample was conducted using 125 V/cm, while adduction
potentials of 345 and 276 V/cm were applied to sample and waste reservoirs,
respectively, to prevent extraneous sample leakage into the separation channel.
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5.3 Results and Discussion
5.3.1 Universal PCR Products
As seen in the Figure 5.2, these pre-processing steps overall yield DNA duplexes
bearing unique fluorescent labels in order to ascertain whether mutation products
present were derived from the top or bottom strands. This universal labeling strategy
was implemented to eliminate the need for obtaining (expensive) fluorescently-labeled
primers for high throughput scanning over several target loci. In order to verify
successful universal PCR amplification, all amplicons were separated on a 2% agarose
gel and compared to a size standard as seen in Figure 5.3. From this image, a band
intensity measurement relative to the weighted size standard was determined to
quantify the total concentrations for each template in order to determine the relative
yields of the denaturation/renaturation processes.

This was required as high DNA

concentrations (125 ng/µL) and very small decreases in annealing temperature (- 0.2
°C/min) are critical the generation of heteroduplexes. The DNA concentrations of the
amplicons in lanes 2 – 5 were were ~150 ng/µL compared to the negative control
samples containing no universal primers for secondary amplification, which were ~8
ng/µL.
5.3.2 Capillary Separations of Endo V/LDR Products
Prior to microchip analyses, separations of the Endo V/LDR products were
conducted using a commercial ABI 3730 CAE system to ensure the reactions were
successful and to provide a comparison of the microchip electrophoresis to previous
results using capillary array electrophoresis [27]. Figure 5.4 shows the presence of p53
mutations due to the observance of ssDNA bands appearing at 158 and 194 bases
when referenced against the DNA sizing ladder (see Figure 5.4), which have been
[125]

confirmed via DNA sequencing [44]. As depicted in Figure 5.4, the panel on the right is
a simplified band representation of all of the peaks generated from each of the six
electropherograms, which was produced using customized software. As a simplified
representation of the multi-channel output from the CAE system, a band representation
of the CAE electropherogram is shown in the left panel of Figure 5.4 and it was used to

Figure 5.3. A 2% agarose gel/1x TBE running buffer separation verifying the
generation of 350 bp universal amplicons of wild-type and mutagenic targets to be
heteroduplexed. Separation was conducted with a 10 V/cm field strength and DNA was
stained with ethidium bromide.

evaluate treated samples for the presence of mutations within the amplicons from either
the top or bottom strands of the heteroduplexes according to their unique fluorescent
labels. The third set of bands (orange) of relatively low intensity in each lane represents
an internal size standard against which the DNA lengths present were referenced. The
Endo V treated samples in lanes 1 – 3 showed elevated levels of sample cleavage
[126]

resulting in several bands that were <110 bp in size, which were a mixture of primers
and miscleaved products. However, lanes 4 – 6, which were treated with both Endo V
and an LDR, showed a significant reduction in false signal bands generated from Endo
V cleavage events arising from cleavage at fully matched sites. Also, no product bands
were present in the wild-types controls samples as expected (see lanes 1 and 4 in
Figure 5.4).

Figure 5.4. Capillary electrophoretic separations of Endo V and Endo V/LDR treated
DNA samples. Heteroduplexed mixtures of wild-type and mutant DNA amplicons from
LoVo and HT-29 cell lines, respectively, were incubated in the optimized reaction
cocktail conditions, which included a 2 h Endo V reaction at 65˚C.

5.3.3 Microchip Separation of 32 Component Size Standard
In order to determine the ability to generate sufficient plate numbers and
resolution for the Endo V/LDR products required for this mutation scanning assay,
which range in size from 100 bp to 350 bp, we optimized the microchip separation
[127]

conditions using a 600 bp sizing ladder composed of 32 single stranded DNAs as a
reference. As shown in the electropherogram in Figure 5.5, a PMMA microchip filled
with a 2.75% (w/v) nanogel [45] suspended in 1x TTE and 7 M urea following a channel
flush with 0.05% (w/v) MHEC (for EOF suppression) was capable of providing near
baseline resolution for all 32 components of this 600 bp sizing ladder having 5, 10 and
20 bp differences in size. This sparsely cross-linked linear polyacrylamide (LPA) was

32 Component 600 bp Size Standard
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Figure 5.5. PMMA microchip separation of a 32 component Beckman 600 bp size
standard. The separation was performed using a 2.75% w/v nanogel constituted in 1x
TTE, 7 M urea buffer with a separation voltage of 125 V/cm at a detection length of
6.0 cm.
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reportedly synthesized by incorporating a low percentage (~10-4 mol %) of N, Nmethylene bisacrylamide (Bis) cross-linker in high-molar mass LPA, which generates
localized cross-linking whereby ~75% of the polymer chains in the nanogel incorporate
at least one point of cross-linking.and allows LPA to remain fluid [45]. We found this
nanogel matrix provided ~18% greater resolution than a 4% LPA matrix prepared with
the same buffer constituents, which was determined by the differences in the respective
resolutions between 100/110, 300/320 and 580/600 bp markers of size standard
separations. The PMMA microchip separations were conducted at field strength of 125
V/cm with sample adduction fields of 345 and 276 V/cm and an effective column length
of 6.0 cm. The high resolution generated for this size standard separation using the
PMMA microchip with the nanogel matrix was therefore considered to be a viable
combination for the sorting of cleaved, miscleaved and uncleaved DNA fragments within
the Endo V and Endo V/LDR treated samples.
5.3.4 Microchip Separation of Endo V/LDR Products
The described LIF system used in conjunction with the microfluidic chip was
capable of only single color detection. Therefore, only one of the two labeled mutations
(dye1-labeled 194 bp product) was analyzed in this assessment. Figure 5.6 shows the
separation results of a negative control, which consisted of 1:5 mutant and wild-type
p53 exon 8 sequences from HT-29 and LoVo cell lines, respectively. Here, no Endo V
enzyme was added during the final treatment incubation. This microchip separation as
well as the Endo V and Endo V/LDR separations were also performed using a 2.75%
(w/v) nanogel constituted in 1x TTE, 7 M urea buffer with a separation voltage of 125
V/cm at a detection length of 6.0 cm. Upon separation development, the only visible
components in the sample were residual fluorescently-labeled PCR primers remaining
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after the PCR amplification and the 350 bp heteroduplexed PCR amplicons, which were
in the single-strand form via denaturation with formamide prior to performing the
separation. This Endo V control
212.5microchip and was completed within 6 min comparable
to the same separation performed on the CAE system (data not shown). Thus, all other
peak fragments present in the Endo V treated samples upon microchip sorting were
attributed to Endo V activity.
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30000
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350 bp PCR Product
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Figure 5.6. PMMA microchip separation of a negative control sample, which was not
subjected to Endo V treatment. Electrophoretic run conditions were the same as those
given in Figure 5.5.
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As seen in Figure 5.7, the microchip separation of an Endo V treated 1:5
mutB/wtA sample using the same conditions given in Figure 5.5 reveals that several
fragments of wtA/mutB heteroduplex, which were not present in the negative control
PMMA microchip separation.

Upon evaluation of the separations, most of the

miscleavages resulted in several partially resolved fragments ranging from the excess
primer peaks used for the universal amplicon generation (~20 bases) to approximately
110 bases.

Therefore, these peaks represented false signals due to non-specific

cleavage as measured against the size standard separation, which were similar to those
observed in the CAE separations (see lanes 4 – 6 of Figure 5.4). As seen, the resulting
microchip Endo V separations were in agreement with the elevated presence of
amplicon fragmentation just prior to the 158 and 194 base mutation products of the
Endo V separations performed on the CAE system.

Interestingly, the microchip

efficiencies of the Endo V separations were relatively low (N = 1.42 x 105 plates/m) in
comparison to that obtained in the microchip separation of the size standard (N = 1.2 x
106 plates/m), which was determined by measuring a peak in both electropherograms
located at approximately 300 s. This could possibly be attributed to high levels of
miscleaved fragments of the same approximate size, which may have co-migrated as
higher efficiencies of the Endo V sample peaks in the CAE separations (i.e., N ≥ 7.0 x
106) were measured. The low sample recovery following the desalting sample prior to
analysis on the microchip could also be a factor. The peak present at Tm= 304 s was
determined to be the 194 base mutation product upon comparison to the size standard,
which has a 200 bp marker at Tm= 298 s. This microchip separation was completed
within 6 min compared to the CAE system, in which the analysis time was
approximately 1 h.
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Figure 5.7. PMMA microchip separation of a wtA/mutB Endo V treated heteroduplex.
Run conditions were the same as given in Figure 5.5.

The separation of a 1:5 mutB/wtA sample treated with both Endo V and a
concurrent LDR is shown in Figure 5.8. As observed in the parallel CAE separations,
fewer peaks generated via miscleavages from Endo V activity were present after the
LDR repair treatment, which suppressed several spurious signals in the 100 – 110 bp
range preceding the expected product location at 194 bp. The peak profile for this
microchip analysis was also similar to the CAE separations of Endo V/LDR treated
samples (see lanes 1 – 3 of Figure 5.4). Upon comparison to the 600 bp size standard,
it was determined that the pronounced peak present following LDR resealing having a
migration time of 290 s was the 194 bp mutation product as it was within close proximity
(Δtm= 8 s) to the 200 bp marker. The efficiency for the 194 bp product peak was 2.91 x
[132]

105 plates/m, which was slightly greater than that of the same product detected in the
Endo V only treated sample. Upon the completion of a two-color LIF system, the size
standard will be internalized in the same separation to further validate the Endo V
product identities.

The relative differences in overall signal intensities of these

microchip electropherograms were also attributed in part to low sample recovery
efficiencies following a desalting procedure.
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Figure 5.8.
PMMA microchip separation of a wtA/mutB Endo V/LDR treated
heteroduplex. Upon LDR treatment, the 194 bp p53 mutation product is observed. Run
conditions were the same as given in Figure 5.5.

5.4 Conclusions
The PMMA microchip separation of sporadic p53 mutations interrogated using a
novel, dual-enzyme Endo V/LDR assay provided some interesting results when
[133]

477

compared to CAE analysis of these sporadic mutations.

The preliminary results

suggest that Endo V/LDR products could be successfully separated and detected on the
PMMA microfluidic filled with a sparsely cross-linked replaceable polyacrylamide in
solution in less than 6 minutes, which was approximately a tenth of the development
time of the 1 h CAE performance. Comparing the Endo V negative control, Endo V and
Endo V/LDR sample separations, characteristics of Endo V cleavage and the
subsequent clean-up of spurious false signals were observed in microchip separations,
which were similar to that obtained with CAE separations. A two-color LIF system is
currently being devised to allow the full two-color read-out of the existing multiplex
assay. Also, front-end sample processing including the universal PCR and
heteroduplexing of target DNAs could be integrated on-chip reduce the ~5 h sample
preparation time presently required.
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Chapter 6: Conclusions and Future Work
6.1 Conclusions
The ever growing understanding of DNA and its linkage to disease development
has demanded vast improvements in genotyping technology. The abundance of DNA
processing necessary to further this base of knowledge has far out-paced antiquated
slab gel systems and even the capillary array systems, which greatly aided in the
completion of the sequencing of the human genome.

Undoubtedly, the current

miniaturization of electrophoretic platforms represents the future of DNA processing
technology. It is expected that the development of polymer microchip separations for
DNA analyses presented in the preceding chapters will be a significant contribution in
the advancement of genotyping technology.
The evolution of genotyping platforms was alluded to in Chapter 1. The
fundamentals of DNA structure/composition and processing including DNA replication
(PCR) and genotyping methods as well as the electrophoresis and fluorescence
detection of DNA were introduced.
The current and noteworthy genotyping accomplishments using microchips as
electrophoretic platforms were discussed in Chapter 2. This chapter expanded in depth
on the growing field of miniaturized separation devices for mutation screening and
scanning, forensics and sequencing applications. Highlighted in this chapter were the
myriad of genetic conditions currently being investigated using microfluidics and trends
of the increasing utilization of polymer substrates for the development of planar
microelectrophoretic platforms. In addition, microchip devices featuring high throughput
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architectures and unprecedented levels of integration for front-end sample manipulation
allowing complete lab-on-a-chip processing of DNA samples were reviewed.
Polymer microchip sorting of mutation products derived from a novel LDR assay
was premiered in Chapter 3. Although widespread utilization of this Taq ligase-based
genotyping technique was evident in the scientific literature since its inception in 1991,
no microchip sorting adaptations of LDR products, including polymer and glass
substrates, had previously been demonstrated. Recognizing the potential value of this
genotyping

method

on

a

miniaturized

electrophoretic

platform,

a

productive

collaboration with the research group of Francis Barany at Weill Medical College of
Cornell University was forged leading to the initial polymer microchip separations of
LDR products. Evaluating a host of polymer solutions, a 4% LPA solution was found
favorable in providing high efficiency separations for an individual LDR product from its
reaction constituents with adequate resolution in the small fragment size range of
interest in as little as 120 s, nearly 17-times faster than capillary gel formats.

In

addition, sample processing prior to the electrophoresis was simplified by eliminating
the need of desalting using ethanol precipitation or other similar techniques. Later, it
was demonstrated that two simultaneously generated LDR products of a 1 to 100 low
abundance mutation ratio could be effectively resolved on the same microchip using a
sparsely cross-linked, low viscosity solution in approximately 4.5 min.
Directly stemming from the challenges presented in adapting the separation of
relatively small LDR products onto a polymer microfluidic, a novel strategy of separating
LDR primers in free solution was developed as described in Chapter 4. In collaboration
with the Barron Research Group of Stanford University, LDR and ELFSE were merged
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for the first time by redesigning LDR primers to allow attachment of molecularlyengineered set of polyamide drag-tags, which imparted unique frictional forces on DNAs
having essentially the same size. Following the development of reaction conditions
amenable for both drag-tag and LDR constituent fidelities, free solution electrophoresis
cross injection and separation conditions were developed and optimized to sort LDR-dt
products on PMMA microchips. Although the single base size differences of these LDR
products were miniscule in terms of relative electrophoretic mobility for small DNA
fragments, baseline resolutions were achieved for four clinically relevant colorectal
cancer mutations. Low abundance mutation detection levels of 1 in 100 DNA molecules
and simultaneous detection of multiple (four) mutations were achieved. Implementation
of this free solution separation mechanism, LDR analysis times reached a new low of
approximately 85 s using a PMMA microfluidic, improving upon the rapid 2 min analysis
times achieved using the same PMMA microchip filled with a host of polymer solutions.
With the understanding gained from previous studies evaluating gel matrices for
DNA separations on polymer microchips, the microchip separation adaptation for
mutation products of a novel Endo V/LDR mutation scanning technique was initiated as
presented in Chapter 6. Combined with LDR resealing of spurious DNA clipping, Endo
V mutation cleavage provided an effective means of detecting unknown mutations
occurring sporadically with high frequency within tumor suppressor genes. Given its
effectiveness, it was found appealing to bolster the processing efficiency of the
technique as the size of Endo V/LDR products fell within a suitable range (> 100 bp)
favorable for microchip separations.

Preliminary results indicate that microchip

separations allow discrimination of Endo V-treated DNA samples from Endo V/LDR-
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treated DNA samples as the latter shows fewer peaks, which could be directly attributed
to Endo V cleavage and the subsequent resealing of DNA targets.

Upon full

optimization of the separation parameters in conjunction with the completion of a twocolor LIF system, we expect to dramatically reduce the mutation product separation
performance by at least a factor of ten as observed in the preliminary data.
6.2 Future Work
As alluded to throughout this dissertation, the next critical step necessary to
realize the promise of transitioning DNA separations onto a miniaturized planar platform
is the integration of DNA sample preparatory processes onto the same wafer. Such
studies have already begun by coworkers within the Soper Research Group for frontend LDR thermal cycling using a miniaturized continuous flow device. To date, only onchip microarray or off-line CE-LIF detection strategies have been implemented to
complement this process. Up until now, the major bottleneck constraining the post
reaction electrophoretic sorting of LDR products has been the incompatibility of viscous
polymer solutions within the continuous flow system. With the development of LDRFSCE in hand, seamless on-chip integrated post reaction separations of LDR-dt
products should now be implemented with relative ease. In addition, high throughput
format separations employing multichannel devices will be pursued in conjunction with
LDR-FSCE since no viscous polymer solutions, which currently influence the choice of
channel geometries, will be necessary for separations. Upon the receipt of a larger set
of polyamide drag-tags, a multiplexed LDR assessment for the entire panel of 19 known
K-ras mutations will be conducted. This strategy will be employed for other mutation
groups having a high association with other forms of cancer developments as well. This
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work will continue until µTAS units for the rapid and cost effective clinical testing of DNA
samples are fully developed.
Polymer microchips separations of Endo V/LDR mutation products will continue
to be investigated. Upon the completion of a two-color LIF system, which is currently
being devised, Endo V/LDR products separations on this platform will be amenable to
two-color read-out as intended with the design of the assay.

Once Endo V/LDR

separations are optimized on this microfluidic domain, front-end sample processing
including the universal PCR and heteroduplexing of target DNAs could be integrated onchip in a similar continuous flow setup as currently developed for LDR to reduce the ~5
h sample preparation time presently required.
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